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The chemical constituents of four Lauraceae species indigenous 
to South Africa, namely, Ocotea bullata, Cryptocarya woodii, 
C. latifolia and C. myrtifolia, were investigated. The species 
yielded eight novel compounds and one known constituent among 
them. 
The three types of compounds isolated include, two neolignans 
(ocobullenone (i) and bullatone (ii)), five 6-substituted 
5,6-dihydro-a-pyrones, cryptofolione (iv) and myrtifolione (v) 
including the known compound goniothalamin (iii), and 
cryptocaryolide A (vi) and B (vii), and two macrolides 
























Flash chromatography technique and the chromatotron were 
central in the isolation of the compounds. Structural 
elucidation included the use of techniques such as IH and 13C 
NMR spectroscopy, HETCOR, DELAYED or RELAY HETCOR, COSY and 
DELAYED or RELAY COSY, NOE, ROESY, HMBC, IR and mass 
spectroscopy. These techniques were instrumental in the 
satisfactory or complete assignment of the proton and carbon 
atoms of the compounds isolated. Chemical modifications were 
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This investigation concerns itself with the study of the 
chemical constituents of four plants belonging to the family 
lauraceae; one species of Ocotea (Ocotea bullata) and three 
species of the genus Cryptocarya (c. woodii, C. latifolia and 
C. myrtifol ia) . 
1.1. DESCRIPTION, DISTRIBUTION AND ETHNOMEDICINAL USES OF THE 
PLANT SPECIES INVESTIGATED. 
1.1.1 Ocotea bullata (Burch.) Baill. 
O. bullata is a medium to large evergreen tree that grows as 
high as 8-30m. 1 The bark is brown and scaly when old and pale 
and attractively coloured in young plants. The leaves are 
large, dark green, glossy and oblong and of the dimension 5-
x 2.5-5 cm. Conspicuous on the leaves are blisters or 
'bubbles' on the upper surface in the axils of the veins 1 
(Plate 1) . The blisters or bullae, as they are botanically 
known, give the plant its specific name 1 . 
The plant occurs in most of the high forests in South Africa. 
It is found in the eastern Transvaal and from the north coast 
of Natal along the coastal areas, down to the western Cape 
(Plate 1).1 
The plant is known as umNukane in Zulu or Black Stinkwood in 
10 
2 
English. Both names are derived from the smell, perceived to 
be unpleasant, of the freshly cut timber and bark. The timber 
is commercially used for furniture and panelling and was used 
in the past by the Afrikaner for wagon construction. The bark 
is used in folk medicine as a headache remedy either by 
inhaling the smoke from burning it or by snuffing the powder. 2 
The powdered bark is also used as a local application to the 
bladder in urinary disorders. 3 Ocotea bullata has been 
declared a protected species in South Africa. 1 
l.l.2. Crptocarya woodii Engl. 
C. woodii is a small to medium sized tree, 5-10m, that 
occasionally grows up to 15 to 20m in height. The bark is grey 
and smooth. The leaves are mid-green, silky-textured, ovate 
and small, 1.5-8 x 1.5-4cm1 (Plate 2). The plant occurs in the 
woodlands, in forests, in river valleys and on forest margins. 
The trees are found in the north eastern to south eastern 
Transvaal and from the southern part of Mozambique along the 
coast, down to the eastern cape {Plate 2).1 The plant is also 
known as the Cape laurel in English and umThungwa in Zulu. 2 
1.1.3. Cryptocarya latifolia Engl. 
C. latifolia which is known as a broad-leaved laure1 1 and 
umHlangwenya 2 in English and Zulu respectively, is a large tree 
that can grow up to 20m. The bark is grey-brown to light 
brown, smooth, and has fine vertical fissures and horizontal 
ridges occurring occasionally. The leaves are broadly oval and 
are 5-10 x 2-4cm in size. They are leathery, dark green and 
finely velvety above, greenish or cinnamon-brown below, and 
later becoming dull bluish-green. The apex is broadly 
tapering, rounded or notched and the petiole is short (Plate 
3) • 1 
3 
The tree occurs in evergreen forests from the north to the 
south coast of Natal (Plate 3).! The plant is used in Zulu 
folk medicine, by mixing the ground bark with crocodile fat, as 
an ointment to treat chest complaints . ! 
1.1.4. Cryptocarya myrtifolia Stapf. 
C. myrtifolia which is known as umGqabe in Zulu, 2 is a medium 
to large tree that grows from 10 to 20m. The bark is brown and 
smooth and the young branchlets are velvety. The leaves are 
small,S x 1.S-2 . Scm, green above and bluish below, lanceolate 
to broadly obovate. The apex is broadly tapering and sometimes 
abruptly and shortly attenuate, while the base is tapering 
(Plate 4).! 
The distribution of this Cryptocarya species is from the far 
north coast to the easter~ Cape (Plate 4). Cryptocarya 
myrtifolia borrows its English name, Camphor laurel, from the 
fact that the bark, twigs and leaves have a distinct smell of 
camphor . ! 
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Neolignans are a group of secondary plant metabolites that are 
structurally characterized by the presence of two aryl 
propanoid (C 6 .C 3 ) units.
4 Harworth S introduced the term 
'lignan' to express the woody tissue from which many examples 
derive, and implied structures that consist of two units 1a 
and 1b linked 8-8' (~-~ ' ). The name 'neolignan' was conceived 
9CC( 9 ' C 
I I 
8 C C 
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by Gottlieb 6 , initially for compounds containing two aryl 
propanoid fragments that are linked otherwise than ~-~'. 
Neolignans were recently redefined 7 as the products of 
oxidative coupling of allyl- or propyl phenols. 
1.2.2. Nomenclature and numbering 
Neolignans show very varied structures, and more than fifteen 
subgroups have been identified, including the frameworks 7 2-5 




Trivial names proliferate and are still being introduced, even 
where systematic nomenclature is uncomplicated. In spite of an 
assortment of skeleta and functions, application of systematic 
nomenclature to neolignans is still discernible. The Ar.C 3 
group is written towards the left . Its C-atoms are numbered 
1-9, while the carbon atoms of the additional C6 .C 3 unit are 
numbered B 1 ' -9 ' , as in Scheme 1 . Direct or oxygen links 
between the units are indicated by identification of the 
bridgehead positions through the smallest possible numerals, 
example 7.3' (and not 7.5'), 8.1 ' in compound 5 Scheme 1. 
1.2.3. Types of neolignans 
Neolignans are classified into subgroups according to the point 
of linkage of the two C6 .C 3 units, example 8.1' (2), 8.0.4' (4) 
and 7.3 ' ,8.1 ' (5) neolignans. Two types of neolignans are of 
direct interest in this work; the (8 . 3 ' )-neolignans and 
8 
neolignans with two doubly linked C6 ,C 3 units. 
1.2.3.1. ~')-neolignans 
These have an oxygen bridge between the two C 6 ,C 3 units, 
forming benzofurans (e.g. carinatin (6) 9 and carinatidin (7) 10) 
and dihydrobenzofurans (e.g. kadsurenone (8) 11 and 28,38-
dihydrocarinatidin (9) .10 Compounds without such a bridge 
include (-) carinalol (10) 9 and lancifolin F (11) .12 These 













1.2.3.2 . Bicyclo [3.2.1] Octanoid neolignans 
Bicyclo [3.2 . 1] octanoid neolignans are a group of 
neolignans whose C6 ,C 3 and C6 , . C3 , units are double linked 
such that the units form a bicyclo [3.2.1] octane system. A 
survey of Brazilian species of plants by Gottlieb and his group 
has uncovered an abundance of new examples with the general 
skeleton 8.1' ,7 . 3 ' and variations of stereochemistry and 
oxygenation pattern . These include rel-(7S,8R,l'R,2 ' R,3 ' S,4S} 
~8'-4 ' -acetoxy-2'-hydroxy-3,3 ' ,S'-trimethoxy-4,S-
methylenedioxY-1', 2', 3 ' , 4 '-tetrahydro-7.3 , ,8.l'-neolignan 
(12) from a species of Ocotea 13 , rel-(7S, 8R, l ' R, 2 ' S, 3 ' R, 
I I 8 t I ' . I J • 
4 R,S S)-~ -2,4 -dlhydroxy-3 ,5 -dlmethoxy-4,S-methylenedioxy 
-1 ' , ·2 ' , 3 ' , 4 ' , 5 ' , 6 ' -hexahydro-7.3 ' ,8 . 1 ' - neolignan (13), 
from an Amazonian species of the genus Aniba,14 and canellin-C 














In the variations of bicyclo [3.2.1] octanoid neolignans that 
have so far been discovered, two features are common. The 
first is that the neolignan either bears a hydroxy, methoxy, 
acetoxy or a carbonyl group on the bridgehead carbon (example 
C-2 in 12, 13 and 14. The scarcity or absence of a 
methylenedioxy group on the C6 , .C 3 , ring is also a noticeable 
feature of the bicyclo [3.2.1] octanoid neolignans previously 
isolated. Secondly, if the allyl group is located at the 
carbons at the intersection of the two rings forming the 
bicyclo system, its attachment is such that it results in a 
11 
8.1 ' instead of 8.3 ' linkage (i.e. bicyclo [3.2.1] octanoid 
systems with the allyl group adjacent to the aryl group have 
not been isolated until recently) .16 
1.2.4. Biosynthesis of neolignans 
Substantial proof, in the form of studies involving carbon and 
oxygen-labelled precursors, on the biosynthesis of neolignans 
has yet to be reported. Gottlieb et a1.,8 however, propose 
that the biogenesis of the majority of neolignans can be 
rationalized by: 
i) the oxidative coupling of a propenylphenol 15 
derived starter with either a propenyl or an 
allylphenol 16 derived termination unit or 
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Scheme 2 
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The mechanism of the coupling of two radicals was proposed by 
Erdtman,17 who suggested that the coupling step should produce 
a quinone methide intermediate (example 17a and 17b, (Scheme 3) 
which may add water, hydroxyl, hydride or carbanion. This 
biosynthetic pathway can be postulated to explain the 
biogenesis of benzofurans and bicyclo [3.~.1] octanoid 











1.2.5. Biological activity of neolignans 
In spite of a phlethora of neolignans that have been isolated 
from plants, extensive investigation on the pharmacology of 
neolignans or the effect of neolignans on plants, has not been 
reported to date. Studies concerning the function of neolignans 
on plants would seem rewarding in view of the insect 
antifeeding properties 18 of piperenone (22). 
OH 
OMe OH OH 
22 23 
Investigations towards the pharmacologic activity of neolignans 
should draw inspiration by their structural proximity to those 
lignans, such as nor-dihydroguaiaretic acid (23) which has been 
implicated in cancer therapy and which acquired such 
importance. 19 Nor-dihydroguaiaretic acid (23) is also used 
industrially as an antioxidant for food material. 8 Schizandrin 
(24) was found to be one of the active ingredients of 
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Otobain (25) and co-occurring neolignans, were found to be 
antifungal components of otoba butter, used in Columbia in 
veterinary practise. 8 
1.3. 6-SUBSTITUTED 5,6-DIHYDRO-a-PYRONES 
1.3.1 . Introduction 
pyrones constitute an import,ant class of compounds as the 
pyran-2-one moiety is found in a large number of natural 
products. Pyrones have been isolated from an extensive range 
of natural resources, such as plants (example 10-epi-olguine 
(26) from Hyptis capitata,20 a tropical herb), animals (example 
bufalin (27) from Bufa vulgaris (toad)), 21 insects (example 
mossoilactone (28) from two species of Australian ants, where 
it forms part of the ant's defence mechanism) ,22 and microbial 
organisms (example, the polyene-pyrone citreomontanin (29), 
which was isolated from Penicillium pedemontanum) .23 However, 
in order to keep this discussion to an acceptable length, only 











6-Substituted 5,6-dihydro-a-pyrones are widely distributed in 
fungi and higher plants. They have, however, been frequently 
found in plants of the families, Lamiaceae, Piperaceae, 
Annonaceae and Lauraceae. They have been isolated in all parts 
of plants including fruits, flowers, leaves and bark.24 
It is interesting to note that regardless of the wide 
distribution of 5,6-dihydro-a-pyrones in both plants and fungi, 
17 
they rarely occur together with a-pyrones 24 and have been found 
coexisting only in three species. 25 , 26, 27 
1.3.2. Nomenclature and numbering of 6-substituted 5,6-dihydro-
a-pyrones 
Uniformity within the nomenclature of 6-substituted 5,6-
dihydro-a-pyrones is unsatisfactory. Although trivial names 
are widely used, 5,6-dihydro-a-pyrones can be named and 
numbered in two ways according to I . U.P . A . C. recommendations. 2 8 
The first recommended nomenclature system identifies the 
lactone with a corresponding heterocyclic nucleus. Therefore, 
a substituted a,~-unsaturated-8- lactone is named as a 
substituted 5,6-dihydro-2H-pyran-2-one (example 
6-propyl-5,6-dihydro-2H-pyran-2 - one (30) .33 This method is 
accepted by chemical abstracts and is commonly used. It is 
admissible to omit the indicated hydrogen and the numerical 
representation of its position (2H), and also to reduce 






l' 5 8 3 
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30 31 
The lactonization of a carboxylic acid hydroxylated at C-5 and 
replacement of the suffix 'oic' with 'olide' forms the basis of 
18 
the second method (example 2-octen-5-olide or 5-propyl 
-2-penten-5-olide 31) .28 The numbering sequence illustrated in 
(30), where the lactone ring and side chain positions are 
differentiated by numbering the latter with prime numbers, will 
be adopted here. Trivial names will be retained. Where 
trivial names have not been given, the adopted nomenclature 
will be employed. 
1.3.3. Biosynthesis of 6-substituted 5,6-dihydro-a-pyrones 
Biosynthetic studies of only a few 6-substituted 5,6-dihydro 
-a-pyrones have been reported. These include parasorbic acid 29 
(32), aspyrone 30 (33), psilotin 31 (34) and pestalotin 32 (35). 
Most of the studies have been carried out with 13C-labelled 
acetates using 13C-nmr to determine incorporation. 29 ,3o,32 The 
biosynthetic pathway of aspyrone (33) will be discussed here 
since it is one of the most extensively investigated 
6-substituted 5,6-dihydro-a-pyrone to date. 
19 
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Holker and Simpson 33 and Brereton et al. 3o investigated the 
biosynthesis ,of aspyrone (33) from [1- 13C]-, [2_ 13 C]_ and 
[1,2- 13 C2 ] -acetates (Scheme 4a). High enrichment of C-2, C-4, 
C-6 and C-3' from [1- 13 C]-acetate and C-3, C-S, C-1 ' , C-2 ' , and 
C-4 ' from [2- 13C]-acetate was observed. The 13C-nmr spectrum 
of [1,2- 13 C2 ]-acetate enriched aspyrone, showed 13C_13C 
coupling between the following pairs; C-3 and C-4, c-s and C-6, 
C-3' and C-4 ' , thus providing their origin from acetate units 
which have remained intact throughout the biosynthetic 
sequence, to give the labelling pattern in Scheme 4a. 
2 ' 
l' 







Small couplings were observed between C-2 and C-2 , indicating 
that the two carbon atoms must be derived from an originally 
intact acetate molecule which has undergone an intramolecular 
rearrangement during the course of the biosynthesis. The above 
enrichment is consistent with the biosynthetic pathway shown in 
Scheme 4a and indicates that aspyrone (33) is formed from a 
pentaketide precursor via an intramolecular (Favorski type) 
rearrangement, generating both the observed head-to-head 
linkage of acetate units, and the l,3-coupling between C-2 and 
C-2 ' , followed by the loss of the terminal carboxyl group. 
This biosynthetic pathway was confirmed by Copeland 34 during 
his incorporation studies with 14C_ and 3H-Iabelled acetates 
when he located labelling sites on the degradation products of 
aspyrone. The tritium labelling experimental results of 
21 
Copeland, 34 however, also accommodate the alternative pathway 
to the biosynthesis of aspyrone (the intermediacy of 36), as 
shown in Scheme 4b. 
36 
Scheme 4b 
1.3.4. Biological activity of 6-substituted 5,6-dihydro-
a-pyrones 
Naturally occurring 6-subsituted 5,6-dihydro-a-pyrones exhibit 
a variety of biological activities. A number of them are 
allelochemicals while others are phytopathogenic, antifungal 
and bacterial; one has insect antifeeding properties. 
Pestalotin (35) has a synergistic effect with gibberellic acid 
22 
(GA 3 ) in stimulating the growth of rice-seedlings, 35 while 
asperline (37) displays antibiotic and antifungal activity 
against a spectrum of microbial organisms. 36 Astepyrone (38) 
was reported to exhibit antiulcerogenic activity in rats. 37 
o o o 
37 38 
Alternaric acid (39) was shown to inhibit spore germination in 
a number of fungi. 38 Parasorbic acid 39 (32) and psilotin 40 
(34) inhibit seed germination and plant growth, whereas 
cryptocaryalactone 41 (40) forms part of a growth regulatory 
system. Both phomalactone (41) and antibiotic (U-13,1933) (42) 
are active against bacteria. 23 Compounds 39 and 44 have been 
found to be phytopathogenic. 38 ,29 Toxin 1 (43) is responsible 
for the brown spot disease on lemons and Rangpur limes while 
alternaric acid (39) causes the collapse of tissues and wilting 













Osmundalactone (44) inhibits feeding of the larvae of yellow 
butterfly Eurema hecabe mandarina on the fern Osmunda japonica; 
it is said to be the only naturally occurring 6-substituted 
5,6-dihydro-a-pyrone known to posses insect antifeeding 
properties. 24 Goniothalamin (45) has been shown to exhibit 








A consistent definition of macrolides is still lacking. The 
central commonality in the various definitions of macrolides is 
that they are macrocyclic lactones . Devon and Scott 43 define 
macrolides as macrocyclic lactones (constructed from linear 
precursors of acetate or propionate origin) that have a polyene 
group as one structurally recognizable subset . Manitto 4 4 
describes macrolides as macrocyclic lactones containing a 
saturated and branched aliphatic chain composed of more than 
ten carbon atoms. Mazzei et a1. 45 contend that macrolides are 
compounds whose chemical structure is characterized by a large 
lactone ring containing from 12 to 16 atoms to which are 
attached, via glycoside bonds, one or more sugars. 
According to Mazzei et a1.45 the lactone ring is substituted by 
hydroxyl or alkyl groups, one ketone at C-7 in 12-membered 
macrolides and at C-9 in 14-membered macrolides, and one 
aldehyde group in 16-membered macrolides. This definition, 
however, has several shortcomings. For instance macro1idic 
compounds with more than 16 atoms constituting a ring and 
without a sugar moiety attached have been isolated and defined 
as macrolides as shall be shown latter. 
1.4.2. Classification of macrolides 
Devon and Scott 43 have classified macrolides into three 
categories: 
25 
a) POLYENE MACROLIDES 
These types of macrolides include polyhydroxy and 
conjugated compounds such as mycoticin 46 (46) and 
filipin47 (47) , 
b) NON-POLYENE MACROLIDES 
This category encompasses macrolides such as 
methymycin (8) and narbomycin (49) ,48 
c) MACROLIDIC (MACROLIDE-LIKE) COMPOUNDS 
Compounds constituting this group include colletodiol 
(50), a macrocyclic dilactone 49 and zearalactone 
(51) , 43 























Patterson and Mansuri, 48 however, use the size of the ring to 
classify macrolides. For example, a 12-membered lactone ring 
(e,g. methymycin (48)), a 14-membered lactone ring (e.g. 
narbomycin (49)) and a 16-membered lactone ring (e.g, tylocin 









1 . 4.3. Nomenclature and numbering of macrolides 
Structurally simple macrolides such as the lactone of 
11-hydroxy-trans-8-dodecenoic acid so (53) have been assigned 
names based on the parent hydroxy acid from which they 
are derived . More complex structures such as mycoticin A (46) 
and tylosin (52) are conveniently given trivial names. 
Although naming (trivial) of macrolides is arbitrary, the 
names of macrolides with a sugar moiety attached to them 
generally bear the suffix 'mycin' (example narbomycin (49)), 
whereas those without a sugar moiety have their names commonly 
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According to the numbering system adopted by Vesonder et al.,50 
Kobayashi et al. 51 and Inanaga et al. 52 in the numbering of 53, 
54 and neomethyrnycin (55) respectively, the carbonyl carbon of 
the ester moiety is numbered 1. After all the carbons 
constituting the ring have been numbered, carbons on the 
longest side chain are then numbered followed by the labelling 
of the rest of the carbons. This method, however, has been 
applied only to monolide macrolides. 
1.4.4. Biosynthesis of macrolides 
Both bacteria and fungi have shown that microorganisms are a 
rich source of structurally-unique and medicinally-important 
compounds. Most macrolides discovered to date owe their origin 
to these two microorganisms. A few macrolides, however, have 
29 
been found in insects. Higher plants are seldom, if ever, 
sources of macrolides. It is with this background that the 
biosynthesis of macrolides was studied in bacterial cultures. 
The biosynthesis of several macrolides including tylactone 53 
(56), dehydrocurvularin 54 (57), nonactin 55 (58) and 
erythromycin A (59) and B (60) ,56,57 have been studied. 
Erythromycin A and B were among the first macrolides to be 
discovered and characterized and their biogenesis has been 
extensively studied. 56, 57, 59 It is for this reason that the 





















Erythromycin A (59), R = OH 
Erythromycin B (60), R H 
30 
The proposed mechanism for the biosynthesis of erythromycins 
(Scheme 5) is based on feeding of radioactive propionate and 
methylmalonate to Streptomyces erythreus. 56 The resultant 
macrolides from feeding experiments with [1_ 13C]-propionate, 
were converted to the readily crystalline 2'-benzoate esters. 
The labelled macrolide esters displayed enhanced signals 
corresponding to the expected positions of labelling; carbons 
1, 3, 5, 7, 9, 11 and 13 (Scheme 6). 
Using the same protocol, samples of erythromycin A and B 
2 ' -benzoates were also generated by incorporation of [2_ 13 C]-
propionate. The carbon-13 nmr spectra revealed the expected 
distribution of label based on the appearance of enhanced 
signals corresponding to C-2, C-4, C-6, C-8, C-I0, C-12 and 
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The biosynthetic origin of the alkyl substituents, C-14, C-15, 
C-16, C-17, C-18, C-19 and C-20,21 was established by 
incorporation experiments with diethyl [2,3- 13 C2]-succinate. 
The diethyl [2,3- 13 C2]-succinate was expected to act as an in 
vivo precursor of [2,2'- 13 C2]-methylmalonate CoA generated by 
the action of methylmalonyl CoA mutase, and could therefore be 
considered as an in vivo equivalent of [2,3-13C2]-propionate.56 
The spectra of the resultant labelled erythromycins A and B 
2'-benzoates, showed the expected seven pairs of enhanced and 
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Labelling of the propionate starter unit (C-20,21) is 
presumed 56 to be due to decarboxylation of the methylmalonyl 
CoA. Measurement of 13C_13C coupling constants was used to 
33 
assign the critical methine and methyl groups. 
Although Corcoran 59 showed that the tertiary-OH groups at C-6 
and C-12 are derived from molecular oxygen (0 2), it was Cane 
and Yang 57 who investigated the biosynthesis of the six 
remaining oxygen atoms already present in erythromycins. 
[1-1S02, 1- 13 C]-propionate was incorporated and the results 
also analysed using 13C-nmr (Scheme 7). The peaks corresponded 
to C-1, C-3, C-5, C-7, C-9, C-11 and C-13 in both erythromycin 




R' = desosaminyl benzoate 
R = cladinosyl benzoate 
Scheme 7 
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corresponding to 160_13C and lS0_13C species, the latter 
resonance being shifted upfield, according to the type of c-o 
bond. The results showed that each of the six oxygen atoms 
present in the first-formed aglycone 6-deoxyerythronolide (61), 
was derived from the propionate precursor. Only the carboxyl 
oxygen of the lactone originated from the C-1, 2, and 14 
propionate unit, the ester oxygen having been derived intact 
from the corresponding C-13, 20, and 21 propionate moiety. 
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1.4 . 5. Biological activity of macrolides 
Macrolides are well established as an old class of antibiotics 
known to humans . They have found application since the early 
1950's and are still an important aspect on the chemotherapy of 
infectious diseases and contribute substantially to the world's 
oral antibiotic trade. 60 The discovery of new types of 
macrolides hopes to expand or maintain their role in the 
control of infectious diseases . New macrolides have been 
discovered and synthesised in recent years. The biological 
activity of selected macrolides will be discussed here. 
Amphidinolide F (62) showed some activity against murine 






Amphidinolide J (54) was also found to be cytotoxic. 51 Some 
macrolides (example enterobactin (63), which transport iron 
from the environment into bacterial cells (e.g. Escherichia . 
coli) by forming a macro-bridged hexacoordinate trianion 64) 
were found to stimulate bacterial growth. 62 
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Other macrolides (e.g. 65 and 66) are used by beetles of the 
genera Oryzaephilus and Cryptolestes in their pheromone 
system. 63 Grahamimycin Al (67), a macrodiolide, exhibits 
antibacterial activity against species such as Staphylococcus 
and Pseudomonas. 64 
o 
o 




The four Lauraceae species studied yielded eight novel 
compounds and one known constituent. Structural elucidation of 
the compounds included techniques such as IH and 13C NMR 
spectroscopy, HETCOR, DELAYED or RELAY HETCOR, COSY and DELAYED 
or RELAY COSY, NOE, ROESY, IR spectroscopy, HMBC techniques, 
mass spectroscopy and chemical modifications of the parent 
compounds isolated. These techniques enabled the satisfactory 
or complete assignment of the protons and carbon atoms of the 
compounds and the relative stereochemistry of some compounds. 
Compounds will be discussed in the same manner as they were 
discussed in the introduction (i.e. according to the class to 
which they belong) . 
2.1. NEOLIGNANS 
Two novel compounds that belong to this class were isolated 
from Ocotea bullata. Ocobullenone (74) was isolated from the 
chloroform extract (Experimental, 3.3.1.1.) whereas bullatone 
(74) was isolated from the ethyl acetate extract (Experimental, 
3.3.1.2.) ). The chemical profile of the chloroform extract of 
the bark of Ocotea bullata revealed a number of other compounds 
that were close (on TLC plate) to the two compounds isolated 
from this plant. Most of the compounds were found to be oils 
with very close Rf values and were difficult to isolate with 
the techniques employed. 
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2.1.1. Ocobullenone (68) 
The literature review indicated that plants belonging to the 
family Lauraceae, especially Ocotea species, abound with 
neolignans and more so with bicyclo [3.2.1] octanoid 
neolignans. 65 , 66 , 15, 67 Scrutiny of the spectroscopic data of 
ocobullenone (68) showed that it has certain structural 
features common to neolignans of the bicyclo [3.2.1] octanoid 
type. However, it was discovered that 68 was the first known 
bicyclo [3.2.1] neolignan to be fully deoxygenated at the 
carbon (C-2 ' ) between the bridgeheads. 16 Bicyclo [3.2.1] 
octanoid neolignans usually either have a hydroxy, 68, 69 an 




feature is the methylenedioxy group at the C-3' ,4' position on 
the cyclohexenone ring. The 13C NMR showed 19 resolved peaks, 
comprising (from DEPT) two methyl, five methylene, six methine 
and eight quaternary carbons. Signals due to the 
methylenedioxy groups, 02CH2-3' ,4' (101.3ppm) and 02 CH 2- 3 ,4 
(101.5ppm), were almost superimposing whereas peaks due to c-a ' 
and C-4 (134.4ppm) were on top of each other. An infrared peak 
at 1641 cm- 1 revealed the presence of an a,~-unsaturated 
carbonyl group. Ocobullenone (68) gave a satisfactory C, Hand 
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N analysis and the lH (Appendix 68a) and 13C (Appendix 68c) NMR 
data were in accord with the proposed structure. COSY, DELAYED 
COSY, HETCOR and DELAYED HETCOR (Appendices 68d, 68e, 68f, and 
68g respectively) NMR techniques were employed to prove 
connectivities in the molecule 68. 
Where ambiguities still existed, these were resolved using the 
lH HMBC technique (Table 1). These experiments were 
particularly useful in establishing the position of attachment 
of the benzene ring to the cyclopentane moiety and to locate 
C-5 in the cyclic system. Thus, long range coupling of H-9 
(methyl protons) to C-3', C-7 and C-8 together with coupling of 
H-7 to C-7 and C-6' (Table 1) established the position of the 
linkage in 68 as 7.1' ,8.3' and pinpointed the position of the 
methyl group relative to the allyl side chain. As indicated in 
the Introduction, the 7.1' ,8.3' linkage in ocobullenone is 
unique in that previously isolated bicyclo [3.2.1] octanoid 
neolignans have the common 7.3' ,8.1' linkage. 73 ,74 
Table 1: Significant HMBC correlations for ocobullenone 
68 (2,3- and 4-bond couplings) 
Proton Irradiated Carbon Observed 
H-8 C-4' , C-l' , C-l, C-3' 
H-7'a C-6' , C-7, C-2' 
H-2'a C-6' , C-4' , C-7, C-8, C-7' 
H-7'b C-6' , C-7, C-2' 
H-2'b C-6' , C-4' , C-7, C-8, C-7' , C-9 
H-2 C-7 
H-6 C-7 
°2CH2-3,4 C-3, C-4 
H-8' C-l' 
02 CH 2 - 3 ' , 4 ' C-3' , C-4' 
H-S' C-3' , C-l' 
OCH3 C-S 
H-7 C-6' , C-l' , C-2, C-6, C-7' 
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The relative stereochemistry of 68 was established using ROESY 
technique (Table 2a). Coupling of both H-2 and H-6 with the 
methyl group (H-9), and with H-8, proved the aryl and methyl 
Table 2a: Selected ROESY experimental results for 
68 
Proton Irradiated Observed Enhancement 
H-9 OCH2O-3',4', H-2, H-6 
H-2'a H-8, H-7 
H-8 H-2'a, H-7 
H-7 H-2'a, H-8 
H-2 and H-6 H-7, H-9 
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group to be cis to each other. This feature is also unique in 
that most bicyclo [3.2.1] octanoid neolignans have the aryl and 
methyl groups trans to one another. 7s ,76,77 Since both H-7 and 
H-8 also couple with one of the H-2' protons, these protons 
must also be cis to one another. NOE experiment (Table 2b) on 
69 confirmed the above allocation, and, in particular that the 
Table 2b:Selected NOE experimental results for 69 
Proton Irradiated Observed Enhancement 
H-6' OCH3 , H-2'b, H-S' 
H-9 H-2, H-6 
H-8 H-7, H-9, H-2'a 
H-7 H-8, H-2'a, H-7'a 
allylic side chain is on the same side as H-7, that H-6 
assumes an endo orientation, and that the protons on the 
aliphatic methylenedioxy group are geminally coupled. 
2.1.1.1. Reactions on ocobullenone (68) 
In an attempt to confirm the structure of ocobullenone (68), 
several reactions were carried out. These included: reduction 
with LiAlH4' hydrogenation, reaction with ethylene glycol using 
para -toluene sulphonic acid (pTSOH) as a catalyst, and 
reaction with dilute hydrochloric acid. 
2.1.1.1.1. Reduction of 68 with lithium aluminium hydride 
Reduction with LiAlH4 (Experimental, 3.3.1.1a.) afforded the 
alcohol 69, C21H2406. This proved to be a very useful 
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derivative since it confirmed the presence of an 
a,~-unsaturated carbonyl system. In the iH NMR spectrum 
(Appendix 69a) of 69, clear coupling between the protons H-5 
and H-6' (J=2.7Hz) is observed. The reduction resulted in the 





a,~-unsaturated carbonyl system, especially C-6'and C-4 , 
shifting upfield to 77.5ppm and 154.7ppm respectively 
(Appendix 69c). Mass spectroscopy showed that 69 had M+ 372. 
Connectivities between the various carbons were deduced from 
HETCOR (Appendix 69£), DELAYED HETCOR (Appendix 69g), COSY 
(Appendix 69d) , and DELAYED COSY (Appendix 6ge) spectra. The 
i3C NMR showed 21 resolved signals representing (from DEPT), 
three methyl, five methylene, seven methine and six quaternary 
carbons. The IR spectrum peak (3560 cm- i ) revealed the 
presence of a hydroxyl group which appear as a doublet 
(J=11.9Hz) at 51.56 in the iH NMR spectrum due to coupling with 
H-6' . 
2.1.1.1.2. Acetylation of 69 
The alcohol 69 was acetylated with acetic anhydride in pyridine 
to afford the acetate 69a (Experimental, 3.3.1.1b.). Mass 
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The 13C NMR spectrum (Appendix 69ac) showed 23 resolved peaks 
comprising of, three methyl, five methylene, seven methine and 
eight quaternary carbons (DEPT analysis). The appearance of 
carbons at 170.4ppm (ester carbon) and 20.6ppm (methyl carbon) 
point to 69a being an ester. The disappearance of the hydroxyl 
band (3560 cm- 1 ) and the appearance of an ester carbonyl band 
(1692 cm - 1 ) in the IR spectrum confirmed this transformation. 
Connectivities in 69a were arrived at by comparison with the 
spectral data of 68 and 69 and the interpretation of the HETCOR 
(Appendix 69af), DELAYED HETCOR (Appendix 69ag), COSY 
(Appendix 69ad) and DELAYED COSY (Appendix 69ae) spectra. 
2.1.1.1.3. Hydrogenation of 68 
Ocobullenone (68) was hydrogenated using palladium on carbon 
(Experimental, 3.3.1.1c.) in an attempt to prove the position 
of the double bond at C-4 ' and C-S'. However, hydrogenation of 





Proof for the formation of this product was the appearance of 
extra methyl and methylene groups in both the lH (Appendix 70a) 
and 13C (Appendix 70c) NMR spectra. 
2 . 1.1 . 1.4. Acid-catalyzed hydrolysis of 68 with para-toluene 
sulfonic acid (pTSOH) 
Acetals readily form under acid catalyzed conditions. 7 3 , 74 When 
ocobullenone (68) in benzene was reacted with ethylene glycol 
using pTSOH as a catalyst (Experimental, 3.3.1.1d.) two 
products were isolated, 71 and 72 (Scheme 8). These were not 
the expected products. It was clear from the nature of the 
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two products were crystalline. The proposed structure of the 
major product 72 was arrived at by comparing the spectral data 
of 72 with those of 68. Mass spectroscopy showed that 72 had 
M+ 358. The 13C NMR spectrum (Appendix 72c) showed 18 resolved 
signals. The other two carbons (methine groups, C-2 and C-6) 
were missing from both the 13C spectrum and DEPT. However, 
evidence for the presence of these methine groups was provided 
by the presence of aromatic protons at B6.44 (Appendix 72a). 
Only one hydroxyl group (OH-3', B4.54) was observed. The 
proton at B3.80 (H-8') and the quaternary carbon (C-6') at 
187.69 ppm could only be that far downfield if they were both 
attached to an oxygen atom, indicating that C-6' and C-8' must 
be linked through an oxygen atom. 
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The IH NMR spectrum of compound 71 (Appendix 71a) was also 
compared to that of 68. Mass spectroscopy indicated that 71 
had M+ 376 . The IH NMR spectrum showed the appearance of three 
hydroxyl groups; two hydroxyls (OH-3 ' and OH-a') at 61.63 and 
one hydroxyl group on a vinyl moiety (OH-4') at 64.54. Both 
the protons at 85.06 (H-9 ' ) and 65.75 (H-a ' ) and the 
methylenedioxy moiety (02CH2-3' ,4') at 65.65 that were visible 
on the IH NMR spectrum of ocobullenone (68) had disappeared. A 
new methyl group at 60.63 (H-9') which coupled with H-a' 
(64.79) was observed. 
A mechanism for this transformation is proposed in Scheme 9 . 
This mechanism would suggest that some water was present in the 
reaction mixture. The fact that the hydration of the double 
bond on the allylic side chain of tautomer 71a results in an 
intermediate that is the same as the minor product 71 lends 













2.1.1.1.5. Acid-catalyzed hydrolysis of 68 with dilute (HC1) 
In view of the hydrolysis of 68 by pTSOH, a reaction was 
carried out to determine whether a dilute Hel would also effect 
hydrolysis to give the same products . The reaction was carried 
out in a polar solvent (methanol) (Experimental, 3.3.1.1e.) to 
facilitate dissolution of the aqueous acid (Scheme 10) . 
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Compound 73 (C 21H2406), an oil, was obtained as the product of 
hydrolysis. The molecular structure of 73 was deduced by 
comparison with the spectral data of ocobullenone 68. The 13C 
NMR spectrum revealed twenty resolved signals (with the peak 
due the quaternary carbon, C-4, and the signal due to the 
methine group C-8 superimposing at 134.47 ppm) (Appendix 73c), 
three methyl, four methylene, six methine and eight quaternary 
carbons. lH NMR (Appendix 73a) showed a new OCH 3 group 
(compared to the lH NMR of 68) at 83.84 and the disappearance 
of the 02CH 2-3 ' ,4' at 85 . 65 ) . The proton at 85.48 (H-5 ' ) 
retained its multiplicity (singlet) indicating that no proton 
was introduced adjacent to it. 
The hydrolysis is perceived here to occur via the same 
mechanism as that in the case where p-TSOH was used as the acid 
catalyst . However, methanol acts as the nucleophile instead of 
water (Scheme 11) . 
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Scheme 11 
2.1.2. Bullatone (74) 
h
Me~~ 




The relationship between bullatone (74) and ocobullenone (68) 
is apparent. Bullatone shows the typical 8.3' linkage but the 
7.1 ' bond is severed at the carbon alpha to the carbonyl group. 
A molecular formula of C22H2806 was supported by a high 
resolution mass spectroscopy (HR-MS) peak at 388. The 13C NMR 
spectrum (Appendix 74c) showed 18 resolved carbons comprising 
(from DEPT) four methyl, five methylene, six methine and seven 
quaternary carbons. Two pairs of equivalent carbons - two OCH 3 
groups (attached to C-3 and C-5 carbons) at 56.23 ppm and two 
methine groups (C-2 and C-6) at 153.23 ppm - were superimposed. 
The equivalence of the two methoxy groups is readily explained 
by the presence of a 3,4,5-trimethoxybenzene moiety on the 
C6 ·C 3 unit, a grouping also present in the neolignan aurin 78 












isolated by Matsui 79 and ~8'-3 ' ,6 ' -dihydro - 3,4,3' ,4 ' -bis-
methylenedioxy-6 ' -oxo-8.3'-neolignan (77) obtained by Green and 
Wiener 80, proved very useful for the purposes of comparison. 
The substituted benzene ring and propyl side chain were 
identified without difficulty. 
The allyl side chain at C-l' was discernible from both the lH 
(Appendix 74a) and 13C NMR spectra and the chemical shifts 
were comparable to those found in ocobullenone (68). The 
methylenedioxy group at C-3' and C-4 ' was characterized by the 
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typical carbon shift of 99.9 ppm and the methylene hydrogens at 
85 . 60. The a,~-unsaturated carbonyl moiety had chemical shifts 
very similar to those found in 68 . 
The point of linkage between C 6 ,C 3 and C 6 , C 3 , units in 74 was 
established by the HMBC experiment (Table 3) . 
Table 3: Multiple bond connections observed in the HMBC 
spectra (2,3- and 4-bond couplings) for 74. 
Proton Irradiated Carbon Observed 
H-9 (8 0.99) C-3' , C-7, C-S 
H-2'b (8 1. 79) C-3' , C-l' , C-S, C-7' 
H-S (8 2.09) C-l, C-3' , C-7, C-9 
H-7b (8 2.25) C-l, C-2, C-9 
H-7'b (8 2.27) C- 6' , C-S' , C-9' , C-l' , C-2' 
H-l' (8 2.40) C-6' , C-S' , C-7' 
H-2'a (8 2.56) C-6' , C-4' , C-3' , C-l' 
H-7'a (8 2.69) C-6' , C-S' , C-9' , C-l' , C-2' 
H-7a (8 2.S7) C-3, C-l, C-2, C-3' , C-S, C-9 
OCH3 -4 (8 3.S0) C-4 
OCH3 -3,5 (8 3.S2) C-3 
H-9' (8 5.07) C-S' , C-7' 
H-5' (8 5.53) C-6' , C-4' , C-3' , C-l' 
°2 CH2 (8 5.60) C-4' , C-3' 
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The relative stereochemistry at C-1'and C-3' was deduced from a 
lD NOE difference experiment (Table 4) on 74. The trans 
relationship between the group attached to C-1' and that 
connected to C-3' was shown by a large NOE between H-1 ' and H-8 
and between H-9 and H-1'. The planarity constraints of the 
a,~-unsaturated carbonyl system coupled with the requirements 
of the methylenedioxy group lend substantial rigidity to the 
cyclohexenone ring resulting in a half-chair or pseudo-chair 
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Table 4: 1D NOE Difference Experiment on 74 
Proton Irradiated Observed correlated proton 
H-9(60.99) H-2, H-6, H-S , H-2'a 
H-S(62 . 09) H-2, H-6 , H-9, H-l' , H-7a , H-2'a 
H-l'(62 . 40) H-S, H-S' , H-2'a 
H-2'a(62.S6) H-2'b , H-l' , H-9, H-S' 
H-7'a(62.69) H- S' , H-l' , H-7'b , H-7b 
H-7(62.S7) H-S , H-7'b, ° 2 CH 2 ' H-S , H-2, H-6 
conformation. Carbons 1 ' , 6 ' , 5 ' , 4 ' , and 3 exhibit a 5-point 
coplanarity . A simple Dreiding model made it abundantly clear 
that the C6 ,C 3 unit can only be attached to an axial bond from 
the cyclohexenone ring. This places the allyl side chain on an 
equatorial bond and trans to the C6 ,C 3 moiety. 
2.2. 6-SUBSTlTUTED 5,6-DIHYDRO-a-PYRONES 
IH NMR spectroscopy has played a major role in the structural 
elucidation of most of naturally occurring 6-substituted 
5,6-dihydro-a-pyrones. Proton H-3 in 78 is coupled to H-4 






olefinic function next to a carbonyl group. Proton H-3 also 
experiences allylic coupling 82 with the two protons attached 
to C-5 (J 3 , sax=lHz, J 3 , seq=2-3Hz). The fact that H-4 
(86.78-7.05) is shielded relative to H-3 is typical of a proton 
attached to the ~-carbon of an a,~-unsaturated carbonyl 
chromophore. Proton H-4 appears as a triplet of doublets from 
its coupling to H-3 and also to H-5 ax (J 4 ,sax=2 - 4Hz) and 
H - 5 e q (J 4 , 5 e q =4 - 6Hz) . 
The two allylic protons at C-5 show a typical geminal coupling 
(J sax , seq=15-19Hz) and a coupling to H-4 and to H-6 
(J sa x , 6=9-12Hz, J Seq , 6=3-6Hz). These two non-equivalent 
protons resonate as a complex multiplet with chemical shifts 
between 82.3 and 82.8. 
2.2.1. Goniothalamin (45) 
This styryl-a-pyrone 45 was isolated from Cryptocarya woodii 
(Experimental, 3.3.2.1.). It has been isolated before from 
other plant species83, 42 and both its molecular structure and 
absolute configuration have been thoroughly investigated. The 
molecular formula of C13H1202 was arrived at from the analysis 
of spectral data. Mass spectroscopy show that goniothalamin 





The 13C NMR spectrum showed eleven resolved carbon signals 
(Appendix 45c) comprising (from DEPT), one methylene, ten 
methine and two quaternary carbons. The peaks at 126.67 ppm 
and 128.67 ppm were almost double the size of other methine 
groups and this was attributed to the overlapping of signals 
due to carbons C-4' and C-8' at 126.67 ppm and C-5'and C-7' at 
128.67 ppm. Both the melting point and rotation of the 
isolated 45 were in close agreement to the literature values. 
As earlier shown, 81 , 82 proton H-3 in 45 was coupled to H-4 with 
a coupling constant of about 9.8Hz showing a cis relationship 
between the two protons. Proton H-3 also experienced a long 
range coupling to C-5 with the expected coupling constants 
(J 3 ,sax=1.93Hz, J 3 ,Seq=3.67Hz). Proton H-4 also coupled to H-5 
(J 4 ,sax=3.57Hz, J 4 ,Seq=4.16Hz) as envisaged. The splitting 
pattern due to the two germinal protons at C-5 (Appendix 45a) 
was complex and thus their coupling constants were not 
determined. 
2.2.1.1. Epoxidation of goniothalamin 
Goniothalamin was epoxidized using mCPBA 84 (Experimental, 
3.3.2.1.1.) to give two crystalline products 79 and 80. The 
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epoxide 79 was obtained as the major compound. This is in 




The coupling constants between the oxirane ring protons 
(J 1 " 2,=2.01Hz for 80 and J 1 " 2,=2.04Hz for 79) were 
consistent for trans-oxides (J 1 " 2,=2.0Hz) and not for 
cis-oxides (J 1 , 2 , =4.2-4 . 5Hz) . 83 , 85 Epoxide 80 having a larger , 
J 6 , l' (5.12Hz) and its H-6 proton appearing at a higher field 
compared to that in 79 (J 6 ,1,=3.87Hz) must be the 
threo-isomer.86 
2.2.2. Cryptofolione (81) 
The benzene extract of the bark of both Cryptocarya 1atifo1ia 
and Cryptocarya myrtifo1ia yielded an oily compound 81 
(Experimental, 3.3.3.3. and 3.4.) for which the name 
cryptofolione has been proposed. A molecular formula of 
C19H2204 was supported by a HR-MS peak at 314. The 13C NMR 
spectrum (Appendix 81e) revealed 17 resolved carbon signals, 
consisting of, three methylene, fourteen methine and two 





goniothalamin (45), the two Sp2 methine groups at 126.43 ppm 
and 128.55 ppm had intensities that were almost double those of 
other Sp2 methine groups indicating overlapping of two signals 
each. IR absorption at 700 and 755 cm- l (Experimental, 
3.3.3.3.). A five-proton multiplet at 87.23 in the lH NMR 
spectrum (Appendix 8la) indicated the presence of a 
monosubstituted benzene ring. This was further confirmed by l3C 
resonances at 136.65s, 126.43d (x2), 128.55d (x2) and 127.56d. 
The presence of the two exocyclic trans-disubstituted double 
bonds was indicated by lH NMR which showed two pairs of 
one-proton multiplets with coupling constants of about 16Hz. 
A strong hydroxyl band (3440 cm- l ) and an a,~-saturated lactone 
band (1708 cm- l ) were present in the IR spectrum. The presence 
of an endocyclic double bond was indicated by two Sp2 methine 
groups which couple to each other in the lH-lH COSY spectrum 
(Appendix 8ld) and a coupling constant of 10Hz in the lH NMR 
spectrum showed the cis stereochemistry of this double bond. 
The point of attachment between the a-pyrone moiety and the 
substituent at C-6 was revealed by the coupling (lH-lH COSY 
spectrum) between H-1' (85.63) and H-6 (84.88) and coupling 
between H-2' (85.82) and H-6 and between H-1' and H-6 RELAYED 
COSY spectrum (Appendix 8le)). The position of the methylene 
group C-S' (42,29t ppm) was indicated by lH_lH COSY coupling 
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between H-4 (64.05) and H-5 ' (61.78) between H-6 (64.63) and 
H- 5 ' thus showing that H-5 ' is sandwiched between the two 
methine groups. Coupling in the IH-IH COSY spectrum between 
H-3 (62.28) and H-4 ' (64 . 05) and between H-3' and H-2 (65.82) 
indicated the position of C- 3 ' as that proposed in 81. 
2.2.2.1 . Reactions on cryptofolione (81) 
2.2.2.1.1. Acetonide derivative of cryptofolione 
The relative stereochemistry of cryptofolione (81) at C-4 and 
C-6 ' , as illustrated in structure 81, was established from the 
chemical shifts of the methyl groups on the acetonide 
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Acetonide formation was discovered by Robinson et aI . 87 and 
Tanabe and Bigley 88 as a means of protecting the side chain of 
some corticosteroids. The method was later used (as far back 
as 1964) by Brown and MacBride 89 for assignment of relative 
configuration to flavandiols. Acetonide formation was further 
and recently exploited by Rychnovsky and Skalitzky 90 and Evans 
et al. 91 for stereochemical assignment of compounds containing 
a 1,3-diol moiety. According to these authors, acetonides 
formed from syn 1,3-diols exist in a well defined chair 
conformation with the two methyl group substituents in 
equatorial positions whereas those from anti 1,3-diols exist in 
a twist conformation in order to avoid the 1,3-diaxial 
interactions which would be present in a chair conformation. 
The 13C NMR chemical shifts of the acetonide methyl groups can 
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be used to distinguish between these two conformations and thus 
the relative stereochemistry at these centres. 90 ,91 The 13C 
NMR spectrum of syn l,3-diol acetonides shows an axial methyl 
group at 19 ppm and an equatorial methyl group at 30 ppm, 
whereas that of anti l,3-diol acetonides shows two methyl 
groups at 25 ppm. 
The acetal carbon in acetonides, according to Rychnovsky and 
Skalit zy 90 and Evans et al., 91 also follow a stereoregular 
pattern where in anti diols it resonates above 100ppm, while in 
syn diols acetonides it appears below 100ppm. Based on the 
above analysis, the relative stereochemistry of 81 at C-4'and 
C-6' wherein the acetal carbon C-15' resonates at 100.26ppm and 
both methyl carbons C-16' and C-17' resonate at approximately 
25ppm (Appendix 82c), was deduced as anti as indicated in 
structures 81 and 82. 
2.2.2.1.2. Oxidation of Cryptofolione 
Treatment of cryptofolione (81) with pyridinium 
chlorochromate 92 (Experimental, 3.3.3.3.1b.) effected oxidation 
at the allylic hydroxyl group (C-6') only to give compound 83 
(Scheme 13). Both the 1H NMR (Appendix 83a) and 13C NMR 
OH OH 
Scheme 13 








(Appendix 83c) and the IR spectra supported the occurrence of 
this transformation. A molecular formula of CI9H2004 was 
supported by a HR-MS peak at 312. A hydroxyl band (3460 cm- I ) 
and a ketone band (1720 cm- I ) were present in the IR spectrum. 
Furthermore, an IR absorption band at 1610 cm- I indicated the 
presence of an a,~-unsaturated carbonyl system. A carbon 
signal at 200.46 ppm confirmed the presence of a ketone 
conjugated to a styryl moiety. The oxidation of the hydroxyl 
group at C-6' resulted in the shifting of H-7' further 
downfield (87.51) - even more downfield than the benzene 
protons - and reduced the splitting patterns of both hydrogens 
(on a double bond, C-7' and C-S') to a doublet each (J=16Hz). 
This oxidation product 83 is structurally similar to 






Cryptocarya kurzi by Fu et a1 .. 93 The 13C NMR data of 83 
compared with that of kurzilactone (84) in Table 5. The 
difference between the two 6-substituted 
5/6-dihydro-a/~-unsaturated-a-pyrones is that the double bond 
at C-1'and C-2 observed in 83 is absent absent in kurzilactone 
(84) . 
Table 5: 13C NMR (CDC13) data for compound 83 (50MHz) 
and 84 (62. 5MHz) 
Compound 83 Compound 84 
Position 8e Position 8e 
2 164.8s 2 164.2s 
3 121. 3d 3 121 . 4d 
4 145.0d 4 145.3d 
5 29.62d 5 30.0t 
6 n.95d 6 74.8d 
1 ' 129.8d 
2' 130.9d 
3 ' 39.3t I' 41. 8t 
4' 67.2d 2' 64.1d 
5' 46.2t 3' 47.0t 
6' 200.46s 4' 200.3s 
7' 126.1d 5 ' 126.2d 
8' 143.7d 6' 143.9d 
9' 134.1s 7' 134.2s 
10' , 14' 128.4d 8' , 12' 128.5d 
11' , 13' 129.0d 9' , 11' 129 . 0d 
12' 130.8d 10' 130.9d 
Assignment of C-1S' ,12' and C-9' ,11 may 
be reversed. 
2.2.2.1.3. Acetylation of Cryptofolione 
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Acetylation of cryptofolione (81) ,using the classical method 
involving acetic anhydride and pyridine (Experimental, 






5 ' 3 ' l ' 
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The 13C NMR spectrum of 85 (Appendix 8sc) shows two methyl 
groups (21.17 ppm and 21.06 ppm) and two ester quaternary 
carbons at 170.47 ppm and 170 . 19 ppm. Further evidence of the 
successful acetylation of 81 was the disappearance of the 
signal (83.46) due to the two hydroxyl groups. The acetyl 
groups resulted in the downfield shifting of H-4 ' and H-6' to 
85 . 05 and 85.46 respectively (Appendix 8sa). 
2.2 . 3 . Myrtifolione (86) 
A crystalline trihydroxy styryl a-pyrone 86 was isolated from 
the chloroform extract of Cryptocarya myrtifolia (Experimental, 
3.4.1.). The name myrtifolione was proposed for this 
hygroscopic 6-substituted 5,6-dihydro-a-pyrone. A molecular 
formula of C19H240S was deduced for myrtifolione (86) from 
analysis of both the 1H (Appendix 86a) and 13C (Appendix 86c) 
NMR data and comparison with the spectral data of 82. The 13C 
NMR spectrum showed 17 resolved signals comprising (from DEPT) 





shortfall of four peaks could be explained from the 
superimposition of signals due to two pairs of equivalent 
methine groups on the benzene ring, C-10' and C-14' (127.26ppm) 
and C-11' and C-13' (129.48ppm) and the closeness of the two 
peaks due to C-1 (46.83ppm) and C-3' (46.91ppm). The 
molecular structure of myrtifolione (86) was arrived at by 
comparison of its spectral data with those of cryptofolione 
(81). The absence of the exocyclic double bond at C-1'and C-2' 
was apparent from both the IH NMR (peaks at 55.63 and 55.82 are 
missing) and 13C NMR (signals at 121.61 ppm and 131.33 ppm are 
missing) spectra. The double bond was replaced by a methylene 
group at C-1' and a methine and a hydroxyl group at C-2 The 
methylene group (46.83 ppm) coupled with the proton H-6 in the 
IH_IH COSY spectrum (Appendix 86d). The fact that no coupling 
was observed between any two Sp3 methine groups in the IH-IH 
COSY spectrum confirms the 1,3-relationship of the hydroxyl 
groups as presented in the proposed structure. 
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2.3. MACROLIDES 
The four compounds, cryptocaryolide A (87) and B (88) and 
foliolide A (90) and B (91), which were isolated from the 
three Cryptocarya species, C. woodii, C. Iatifolia and C. 
myrtifolia, will be discussed in turn. To our knowledge this 
is the first time that macrolides have been isolated from 
higher plants. 
These compounds fall short of the definition of Devon and 
Scott 43 in that they don't contain a polyene group as a 
structurally recognizable unit. The absence of one or more 
sugar units in these compounds and the fact that some of them 
contain a lactone ring with more than 16 atoms, disqualifies 
them as macrolides according to the definition of Mazzei et 
al . . 45 Saturated and branched aliphatic chains are not a 
feature in these compounds hence the definition of Manitto 44 
does not fully suit these compounds. (See the Introduction for 
the definition of macrolides according to respective authors. 
However, these four compounds 87, 88, 90 and 91 fit the 
definition of macrolides in that they are macrocyclic lactones. 
All of these compounds were isolated as viscous oils. 
Trivial names, which are mainly based on the names of the plant 
sources, have been proposed for the macrolides isolated. The 
suggested names bear the suffix 'olide' by virtue of the lack 
of attachment of a sugar moiety to these molecules. 
The numbering system of Vesonder et al. 50 has been adopted and 
adapted here. The carbonyl carbon of the ester moiety is 
numbered 1. In the two macrolides with a double bond adjacent 
to an ester moiety (87 and 88), it is this ester carbon that 
has been given the first priority in numbering. The rest of 
the atoms in the ring (including oxygen atoms) are then 
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numbered, in the direction opposite to the oxygen atom of the 
ester group, followed by the bridgehead carbon (in compounds 90 
and 91) and the substituents. 
2.3.1. CRYPTOCARYOLIDE A (87) 
Cryptocaryolide A (87) was isolated from the benzene extract of 
Cryptocarya latifolia (Experimental, 3.3.3.1b). The proposed 
structure of cryptocaryolide A, a 14-membered macrotriolide 
(three ester moieties ) was based on NMR, IR and mass 
spectroscopic analysis. A molecular formula of C14H2006 was 
supported by a HR-MS peak at 284. The 13C NMR (Appendix 87c) 
showed 13 resolved peaks, comprising three methyl, three 
methylene, five methine and three quaternary carbons (DEPT 
analysis). However, an Sp3 methine resonance at 67.62 ppm has 
intensity almost double that of other methine groups and is 
considered to represent two superimposed signals. The mass 
spectrum showed a molecular ion peak at 284. Evidence for the 
presence of an a,~-unsaturated ester or ester group (1690 cm- 1 ) 
was present in the IR spectrum. 
The part of the ring of cryptocaryolide A that includes 0-14, 
C-1, C-2, C-3, C-4, and c-s is reminiscent of the 






5,6-dihydro-a-pyrones. Proton H-2 in structure 87 resonates at 
86.00 (Appendix 87a) and is coupled to H-3 (J=9.76Hz) 
indicative of a cis olefinic function adjacent to a carbonyl 
group. Proton H-2 is also coupled to H-4 by long range 
coupling to the two protons attached to C-4 (J 2 , 4ax=0.96Hz, 
J 2 , 4eq=2 . 44Hz) . The deshielding of H-3 relative to H-2 is 
typical of a proton attached to the ~-carbon of an 
a,~-unsaturated carbonyl system. The signal for H-3, as in 
6-substituted 5,6-dihydro-a-pyrones, appears as a triplet of 
doublets from its coupling to H-2 and also to H-4 ax 
(J 3 , 4ax=2.27Hz) and H-4 eq (J 3 , 4eq=5.80Hz). 
The carbon at C-4 (29.03 ppm) has a typical carbon chemical 
shift for a methylene carbon adjacent to an a,~-unsaturated 
ester moiety. Both the lH_1H COSY (Appendix 87d) and the lH_1H 
RELAYED COSY (Appendix 87e) show that the methine groups are 
not coupled to each other, hence no two methine groups are 
adjacent to each other in the structure. The lH_1H COSY 
spectrum also show coupling between H-4 to both H-2 and H-3 
thus confirming the presence of this moiety in structure 87. 
The carbon (67-75ppm) and the proton (84.4-5.1) chemical shifts 
of the three methine groups indicate that these methine groups 
are each attached to an oxygen atom of an ester group. The 
methylene carbons at 38.94 ppm and 40.12 ppm have chemical 
shifts typical of a CH 2 group attached to the carbonyl carbon 
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of an ester group. The methine group at c-s is coupled to the 
methylene group at C-4 (see IH_IH COSY spectrum) and thus the 
two groups must be adjacent to each other. The IH-IH COSY 
spectrum also shows the methyl group at 19.97 ppm to be 
attached to one of the methine groups at 67.62 ppm. The IH_13C 
DELAYED HETCOR spectrum (Appendix 87g) shows this methyl group 
(19.97 ppm) to also couple to the methylene group at 40.12 ppm. 
This leaves one methylene group (38.94 ppm) which therefore 
must be attached to the other methine group at 67.62 ppm. 
Connectivity of the other methyl groups at 21.01 ppm and 21.14 
ppm could not be determined with certainty since their proton 
signals superimpose with other signals upfield. The methyl 
group at 21.01 ppm is either connected to the methine group at 
67.62 (C-9) or to that at 74.82 ppm (C-S). The same applies to 
the methyl group at 21.14 ppm. 
2.3.2. CRYPTOCARYOLIDE B (88) 
Cryptocaryolide B (88) was isolated from both Cryptocarya 
woodii and Cryptocarya latifolia. However, C . latifolia was 
found to be the richer source of this compound (Experimental, 
3.3.2.2. and 3.3.3.1.). 
The molecular structure of cryptocaryolide B (88), an 
l8-membered macrotetrolide (four ester groups), was derived 
from IR, NMR and Mass Spectroscopic data. In the CI-MS, ions 
at m/z 371 [M+H]+, 399 [M+C 2Hs J + and 412 [M+C 3H7 J + supported 
the molecular ion at 370 mass units. A molecular formula of 
ClsH260S was supported by a HR-MS peak at 370. The 13C NMR 
spectrum (Appendix 88c) showed 17 resolved peaks comprising of 
(from DEPT), four methyl, three methylene, six methine and four 
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quaternary carbons. However, the methylene group at 38.96 ppm 
was more intense than all other methylene peaks and was 
considered to represent two superimposed signals. An 
a,~-unsaturated ester or ester group (1730 cm- I ) was evident in 
the IR spectrum. As was observed in the case of 
cryptocaryolide A (87), proton H-2 in structure 88 resonates at 
86 . 01 (Appendix 88a) and is coupled to H-3 (J=9.76Hz) 
indicating a cis olefinic moiety next to a ester group. The 
long range coupling of H-2 to the two protons at C-4 
(J 2 , 4ax=1.16Hz, J 2 ,4eq=2.49Hz) was also evident in the 
spectrum. Proton H-3 was deshielded relative to H-2; this is 
usual of a proton attached to the ~-carbon of an 
a,~-unsaturated system. 
As in 87, the IH-IH COSY (Appendix 88d ) and IH-IH DELAYED COSY 
(Appendix 88e) spectra of compound 88 show no immediate or long 
range correlation respectively between any two Sp3 methine 
protons. A methine proton instead seemed to couple to both a 
methyl and a methylene proton. On the other hand, coupling 
between the proton at C-4 and carbons C-2 and C-3 were evident 
in the IH_13C DELAYED HETCOR Spectrum (Appendix 88g). The 
IH_13C DELAYED HETCOR spectrum also showed coupling between 
protons at C-19 and the carbon at C-16 and one of the methine 
carbons at about 68 ppm . 
The structure of cryptocaryolide B (88) compares with that of 
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cryptocaryolide A (87). Assuming that the basic units in the 
two structures are a 3-hydroxybutanoic acid and a 
2Z-5-hydroxy-2-hexenoic acid, 88 would have four units of 
3-hydroxybutanoic acid compared to three units in 87. The 13C 
NMR spectra of the 3-hydroxybutanoic acid moieties of the two 
macrolides compare with that of triolide 89 
(R,R,R-4,8,12-trimethyl-1,5,9 -trioxadodeca-2,6,10-trione) 
synthesized by Seebach et al. 94 [ 13c NMR (100MHz, CDC1 3 , TMS): 
820.76 (CH 3), 42.15 (CH 2 ), 68.86 (CH) and 170.02 (CO)]. 
Revised structures of Cryptocaryolide A (87) and B (88) 
Additional spectroscopic data obtained from HMBC experiments 
(obtained after the submission of this thesis to examiners) 
necessitates the revision of the structural formulae 87 and 88. 





Contrary to the initial classification of these two compounds 
as macrolides, 87 and 88 should be reclassified as 
6-substituted 5,6-dihydropyrones. 
2.3.3. FOLIOLIDE A (90) 
Foliolide A (90) was isolated from the chloroform extract of 
Cryptocarya latifolia (Experimental, 3.3.3.1.). There was 
evidence of the presence of this compound in Cryptocarya 
myrtifolia (from a TLC profile) albeit in small amounts. 
The planar structure of this bicyclo - macromonolide 90 was 
deduced by analysis of its IH and I3C NMR data aided by 2D NMR 
experiments. The I3C NMR spectrum (Appendix 90e) shows 12 
resolved peaks comprising, one methyl, five methylene, five 
methine and one quaternary carbons (DEPT analysis). An ester 
group (1675 cm- I ) was present in the IR spectrum. This was 




It was evident from the lH-1H COSY (Appendix 90d) that no two 
methine groups coupled with one another (i.e . not attached to 
each other). The 13C chemical shifts of C-3, C-5, C-7, C-9 and 
C- 11 (65.94-72.62) (Appendix 90c) indicate that these five 
methine carbons are attached to oxygen atoms. The downfield 
shift of H-11 (84.89) in the lH NMR spectrum (Appendix 90a) 
suggests that C-11 is connected to an ester oxygen. Two of the 
protons at 83 . 67-4.11 show no coupling to carbons in the lH_13C 
HETCOR spectrum (Appendix 90£) thus indicating the existence of 
two hydroxyl groups in the molecule. The presence of two 
hydroxyl groups was further substantiated by running a D20 NMR 
experiment (Appendix 90a) which resulted in the disappearance 
of the peaks due to the hydroxyl groups. 
Strong coupling of the methyl (C-13) protons in the lH_13C 
DELAYED HETCOR (5Hz) spectrum (Appendix 90g) to carbons at 
44.89 ppm (CH 2 , C-6) and 68.13 (CH, C-5) indicate the presence 
of a propyl moiety (CH 3-CH-CH 2 ). The downfield shift of H-2 
(82.86) indicates that the carbon to which these protons are 
attached bears an ester group. This was also evidenced by a 
strong coupling of H-2 to C-1 (169.56 ppm) in the lH_13C 
DELAYED HETCOR (12Hz) spectrum (Appendix 90g). The DELAYED 
HETCOR (12Hz) spectrum also reveals a moderate coupling of H-3 
(84.40) and a weak coupling of H-11 (84.89) to C-1. The weak 
H-11 to C- 1 coupling is typical of a through-bond coupling 
interrupted by a heteroatom. The lH-1H RELAY 2 COSY spectrum 
(Appendix 90e) shows weak coupling between H-3 and H-11 
(typical of a through-four-bonds coupling). lH-1H COSY 
experiment (Appendix 90d) shows coupling of H-12 (82.01) to 
both H-3 (84.41) and H-11 (84.89). The lH-1H COSY also shows 
coupling between H-12 and H-2 (82.86). The above experiments 
indicate that H-13 represents the bridgehead methylene group. 
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2.3.4 . FOLIOLIDE B (91) 
The name foliolide B was proposed for the compound 91, which 
was isolated from Cryptocarya latifolia (Experimental, 
3.3.3 . 2.) . The molecular structure and formula (C16H2407) of 
this bicyclo-macrotriolide is based on the mass, IR, lH and 13C 
NMR spectroscopic data . The mass spectrum showed a molecular 
ion at m/z 328. A molecular formula of C26H2407 was supported 
by a HR-MS peak at 328. The carbon-13 NMR spectrum (Appendix 
91c) shows 15 resolved signals, with signals at 170.49ppm 
consisting of two superimposing peaks. The 16 carbon peaks 
comprise, three methyl, five methylene, five methine and five 
quaternary carbons (DEPT analysis). Assignment of protons to 
the respective carbons was done with the aid of the lH_ 13 C 
HETCOR spectrum (Appendix 91£) . 
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The chemical shifts of three of the quaternary carbons at 
169.68-170.49ppm indicate that these must be ester carbons. 
This was confirmed by an IR banj at (1740 cm - 1). The chemical 
shifts of C-3, C-5, C-9, C-13 and C-15 (63.11-72.85ppm) signify 
that these five methine carbons are attached to oxygens. The 
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downfield shift, in the lH NMR spectrum, of H-9, H-13 and H-15 
(64.88-5.09) especially suggest that C-9, C-13 and C-15 should 
bind to ester oxygensi therefore H-3 (64.33) and H-5 (64.96) 
must be attached to ether oxygens. No coupling was observed 
between any two methine protons in the lH-1H COSY spectrum 
(Appendix 91d) indicating that no methine groups immediately 
connect to each other. The implication of the above analysis 
is that the two methine group (C-3 and C-5) are connected to 
each other through an ether linkage since evidence for the 
presence of a hydroxyl group is lacking. 
Structural elucidation of the a-pyrone moiety was not 
difficult. The a-pyrone moiety present in foliolide A (90) was 
found to exist in foliolide B (91). This was evidenced by an 
ester carbon peak at 169.68ppm, two methylene signals at 
36.11ppm and 29.50ppm, two methine peaks at 65.79ppm and 
72.85ppm in the 13C spectrum of 91. Both the chemical shifts 
of H-2 and C-2 and the multiplicity of H-2 in foliolide A (90) 
and foliolide B (91) are comparable. The lH-1H COSY spectrum 
(Appendix 91d) shows coupling of H-3 to both H-2 and H-15. 
Proton H-2 (62.81) also shows correlation in the lH_13C DELAYED 
HETCOR (7Hz) spectrum (Appendix 91g) to C-2, C-3 and C-17. 
The lH-1H COSY spectrum further indicates coupling of H-15 
(64.88) to both H-14 and H-17. lH_13C DELAYED HETCOR (12Hz) 
(Appendix 91g) reveals coupling of H-3 to C-1. The above 
couplings confirm the presence of the a-pyrone moiety and the 
fact that C-17 is the bridgehead carbon. 
Detection of connectivities in the rest of the structure was 
not easy due to overlapping of peaks representing four 
methylene and two methyl groups in the lower field of the lH 
NMR spectrum. Coupling of H-15 to both H-14 and H-17 was 
confirmed in the lH-1H COSY spectrum. It is interesting to 
note that in the lH_13C HETCOR spectrum of both foliolide A 
(90) and B (91) peaks due to the two protons on C-10 and C-14, 
respectively, are distributed as three groups of signals. Such 
distribution of peaks is typical in cyclic structures. The 
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propyl moiety consisting of C-6, C-5 and C-18 was exhibited by 
coupling of H-5 (84.96) to both H-18 and H-6 in the lH-1H COSY 
spectrum, and coupling of H-18 (81.23Hz) to both C-6 and C-5. 
Therefore C-9 (63.11ppm) must be attached to C- 10 (39.87ppm) 
and C-19 (21.23 or 21.34ppm) and C-13 (68.35ppm) must be 
attached to C-14 (36.87ppm) and C-20 (21.23 or 21.34ppm). 
Precise assignment of the two methyl groups C-19 and C-20 was 
difficult. 
Revised structure of Foliolide B (91) 
The revision of the structure of 91 indicates that this 
macrolide is the diacetate of Foliolide A (90) as illustrated 
in the structural formula below. 
o 
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2.4. Biological activity 
The biological activity of the compounds isolated in this work, 
except for goniothalamin (45) has never been studied before. 
Previous studies on 45 revealed that chis 6-substituted 
5,6-dihydro-a-pyrone exhibits central nervous system activity, 
antifungal activity 84 and was found to induce foetal 
abnormalities in mice. 95 
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Similarities in the core structure of macrolidcs such as 
enterobactin (63), which stimulates bacterial growth,6 2 and 
cryptocaryolide A (87) and B (88) may tempt one to suggest that 
87 and 88 to be of biological importance . Indeed plans are 
underway to study the pharmacology of these structurally 
interesting compounds. 
2.5. Concluding Observations 
Given the presence of an o-pyrone moiety in some of the 
macrolides it is tempting to speculate that a relationship 
exists between the o-pyrones and the bridged cyclic compounds 
terminating in an o-pyrone ring . For example, the 
transformation of compound 81 to the macrocycle 92 via Michael 
addition of the allylic alcohol group on the o,~-unsaturated 
system (Scheme 14) is an attractive possibility. 








C . latifolia or C. myrtifolia its resemblance to 90 is quite 
striking. For example, both 90 and 92 are 12-membered bicyclic 




3.1. Instrumentation and Chemicals 
Infrared spectra were obtained using a Shimadzu FTIR-4300 
spectrophotometer. Optical rotations ([0]) were recorded on a 
Perkin-Elmer 241 polarimeter. Mass spectra were obtained using 
Hewlett Parkard gas chromatographic mass spectrometer (HP5988A) 
and a Varian high resolution mass spectrometer. NMR spectra 
were recorded on a Varian Gemini 200 and a U400 
instruments, using TMS as the internal standard, in chloroform 
(unless stated otherwise). Melting points (mp) were recorded 
on a Kofler hot-stage apparatus and are uncorrected. The flash 
chromatographic technique of Still et. al. 95 was employed in 
running columns on silica gel (Merk 60, 230-400 mesh). The 
Harison Research (Model 7924T) chromatotron was used to run 
chromatotron plates on silica gel (Merck 60, PF 254 , 7749) using 
UV (254nm) for detection. Separations in both the flash 
chromatography and the chromatotron were monitored by thin 
layer chromatography (TLC) using small strips of pre coated 
Kieselgel 60, F 254 , Merck plastic sheets. Ultraviolet light 
(254nm) and the anisaldehyde stain 96 were used to detect 
components on TLC plates. Reactions were monitored with TLC. 
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3.2. Preparation and Extraction of Plant Material 
The plant specimens were identified by Mr. R. Scott-Shaw of the 
Natal Parks Board. The plant bark were collected from natural 
specimen, air-dried and milled. Except for Cryptocarya 
myrtifolia, the fine bark was extracted sequentially using a 








The milled bark of Cryptocarya myrtifolia was first extracted 
with absolute ethanol - this was owing to the long delay in 
further extractions of the bark. After the solvent (ethanol) 
was removed, water was added and the extract sequentially 
extracted with benzene, chloroform and ethyl acetate. 
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3.3. Fractionation and Isolation of Compounds 
Each of the solvents was evaporated to dryness, and the 
components present investigated using TLC. Thin layer 
chromatography was employed to develop solvent systems used in 
the fractionation of extracts on the column or chromatotron. 
Fractionation of the plant extracts, the isolation of 
individual compounds and reactions on some of the isolated 
components are discussed under the plant species below. 
3.3.1 . Ocotea bullata 
Bark from a natural specimen of Ocotea bullata was collected in 
the Karkloof range, Natal, South Africa in October 1990. The 
dried bark (4Kg) was extracted as described in 3.2 . . 
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The crude chloroform extract (21.3g) was fractionated by column 
chromatography (cc) using chloroform as eluent. The fractions 
containing ocobullenone (68) were concentrated and further 
subjected to repeated fractionation by cc using ethyl 
acetate-hexane (7:2) as eluent to afford a pure crystalline 
compound (68) (1.56g). 
Rel-(7R, 8R, l ' R, 3'R)-6 8 ' -5-methoxy-bis-3,4;3' ,4'-
methylenedioxy-1 ' ,2' ,3' ,6'-tetrahydro-6'-oxo-7.1' ,8.3' -
neolignan (68). Found: M+ 370.1424; C21H2206 requires 
370.1415. White crystals, mp 151°C, [O]D 25 +204° (CHCI 3; 
cO.16). EI-MS m/s (relative intensity (reI. int.)): 370 [M] + 
(15), 192 (11), 178 (100), 137 (29), 91 (27), 69 (46). 
IRumaxcm-l (KBr disc): 2930, 1641, 1510, 1427, 1363, 1205, 
1176, 1049, 929. IH NMR: 50.85 (3H, d, J=7.42Hz, H-9); 2.05 
(lH, dd, J=14.18, 8.94Hz, H-7'a); 2.06 and 2.26 (2H, dd, 
J=10.50Hz, H-2'); 2.56 (lH, dddd, 14.11, 5.75, 1.39, 1.35Hz, 
H-7'b); 2.87 (lH, dq, J=11.90, 7 . 40Hz, H-8); 3.37 (lH, d, 
J=11.90Hz, H-7); 3.83 (3H, s, OMe); 5.06 (2H, m, H-9'); 5.57 
(lH, s, H-5 ' ); 5.65 (2H, dd, J=0.33Hz, 02CH2-3',4'); 5.75 (lH, 
m, H-8 ' ), 5.88 (2H, dd, J=1.52Hz, 02CH2-3,4); 6.12 (2H, dd, 
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J=1.70Hz, H-2,6). 13C NMR: 614.2 (C-9) i 37.7 (C-7') i 44.4 
( C - 8) i 4 6 . 6 ( C - 2 ' ) i 54. 0 ( C - 7) i 56. 6 ( OMe) i 5 9 . 8 ( C - 1 ' ) i 91. 2 
( C - 3 ' ) i 98. 4 ( C - 5 ' ) i 101. 3 ( 0 2 CH 2 - 3 ' , 4 ' ) i 10 1. 5 ( 0 2 CH r 3 , 4) i 
104.8 (C-6) i 111.2 (C-2) i 118.5 (C-9') i 129.8 (C-1) i 134.4 
(C-4, C-8')i 142.7 (C-5)i 148.5 (C-3)i 177.5 (C-4')i 200.2 
(C-6') . 
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Ocobullenone (68) (100mg, 2.702x10- 4 mol) in dry diethyl ether 
(25ml) was added dropwisely to a stirred suspension of LiAIH4 
(16mg, 4.200x10- 4 mol) in dry diethyl ether (25ml) at such a 
rate as to cause a mild reflux. The reaction mixture was 
cooled in an ice-bath and water (10ml), NaOH (15%, 10ml), then 
water (30ml) were added and the mixture stirred for 30min. The 
aqueous layer was extracted with diethyl ether and the combined 
organic solvents dried over anhydrous magnesium sulphate. The 
reaction yielded 98mg of the alcohol, a yellow viscous oil. 
[0] D
2 5 + 116 0 (CHCI 3 ; cO.42). EI-MS m/z (reI. int.): 372 [M] + 
(67), 283 (20), 242 (29), 192 (100), 141 (29), III (21), 91 
(19). IRvrnaxcm - l (Nujol): 3560, 2910, 1710, 1640, 1515, 1460, 
1328, 1260, 970, 940. IH NMR: 60.97 (3H, d, J=7.40Hz, H-9); 
1.56 (lH , d"J=11.90Hz, OH); 1.80, 2.20 (2H, dd, J=10.40, 
H-2 ' ); 2.25 (lH, dd, J=7.15, 13.78Hz, H-7 ' a); 2.54 (lH, dd, 
J=7.15, 13.78Hz, H-7'b); 2.78 (lH, dq, J=7.30, 12.40Hz, H-8); 
3.23 (lH, d, J=12.40Hz, H-7); 3.90 (3H, s, OMe); 4.47 (lH, dd, 
J=2.70, 11.90Hz, H-6 ' ); 4.99 (lH, d, J=2.70Hz, H-5 ' ); 5.16 (2H, 
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m, H-9 ' ); 5.38 (2H, dd, J=0.8Hz, 02CH2-3 ' ,4'); 5.78-5.99 (lH, 
m, H-8 ' ); 5.95 (2H, dd, J=1.4Hz, 02CH2-3,4); 6.58 (lH, d, 
J=1.4Hz, H-2); 6.63 (lH, d, J=1.4Hz, H-6). 13C NMR: 013.4 
(C-9); 40.6 (C-7 ' ); 44.4 (C-2'); 46.8 (C-8); 52.0 (C-7); 52.4 
( C - 1 ' ); 5 6 . 6 ( OMe); 77. 5 ( C - 6 ' ); 8 6 . 9 ( C - 3 ' ); 95. 0 ( C - 5 ' ); 98. 8 
( 0 2 CH 2 - 3 ' ,4 ' ); 1 0 1 . 5 ( 0 2 CH 2 - 3 , 4); 1 0 4 . 7 ( C - 6); 111. 1 ( C - 2) ; 
118.7 (C-9'); 133.1 (C-1); 134.3 (C-4, C-8'); 142.5 (C-5); 
148.9 (C-3); 154.7 (C-4 ' ). 
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The alcohol (69) (50mg, 1.351x10- 4 mol) was dissolved in 
pyridine (3ml) and acetic acid anhydride (3ml) was added. The 
reaction mixture was stirred overnight. Water (20ml) was added 
and the mixture extracted with chloroform (30ml X 3). The 
organic layer was washed with hydrochloric acid (30ml, 0.5N) 
and dried over anhydrous MgS04 and concentrated to yield 45mg 
of the acetate, 69a, a yellow oil. 
[a] D 25 + 109 0 (CHC1 3 i cO.42). EI-MS m/z (reI. int.): 414 [M] + 
(4), 324 (31), 283 (7), 192 (100), 150 (28), 109 (10), 91 (9). 
IRvrnaxcm-l (Nujol): 2920, 1735, 1692, 1635, 1463, 1379, 1135, 
938, 834. lH NMR: 80.95 (3H, d, J=7.33Hz, H-9) i 1.62 (3H, s, 
COOCH 3 ) i 1.92 (lH, d, J=10.46Hz, H-2'a) i 2.12 (lH, dd, J=7.54, 
13.98Hz, H-7'a) i 2.29 (lH, d, J=10.46Hz, H-2'b) i 2.32 (lH, dd, 
J=7.38, 13.88Hz, H-7'b) i 2.77 (lH, dq, J=12.61, 7.33Hz, H-8) i 
3.25 (lH, d, J=12.62Hz, H-7) i 3.87 (3H, s, OCH 3 ) i 4.97 (lH, d, 
J=2.85Hz, H-5') i 5.13 (2H, m, H-9') i 5.43 (2H, dd, J=0.92Hz, 
02 CH r 3 ',4 ' )i 5.53 (lH, d, J=2.84Hz, H-6')i 5.79 (lH, m, H-8')i 
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5.92 (2H, d, J=1.39Hz, 02CH2-3,4) i 6.50 (2H, dd, J=1 . 55Hz, H-2, 
H - 6). 1 3 C NMR: 013. 56 ( C - 9) i 2 0 . 64 ( COO~H 3) i 4 0 . 77 ( C - 7 ' ) i 
44.69 (C-2')i 46.05 (C-8)i 51.32 (C-1')i 53.09 (C-7)i 56.54 
( OCH 3) i 77 . 92 ( C - 6 ' ) i 87. 14 ( C - 3 ' ) i 90. 54 ( C - 5 ' ) i 98. 98 
( 0 2 CH 2 - 3 ' , 4 ' ) i 10 1. 04 ( 0 2 CH 2 - 3 , 4) i 1 0 7 . 3 6 ( C - 6) i 112. 5 9 ( C - 2) i 
118.97 (C-9')i 132.29 (C-1)i 133.48 (C-4)i 133.67 (C-8')i 
141.66 (C-5) i 147.21 (C-3) i 156.60 (C-4') i 170.45 (~OOCH3)' 
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A suspension of 68 (45mg, 1.215x10- 4 mol) and palladium on 
charcoal was magnetically stirred under hydrogen for 3h to 
yield the crystalline compound 70 (40mg) . 
[ex] D23 + 152 0 (CHC1 3 i cO.243). IH NMR: 00.86 (3H, d, J=7,16Hz, 
H-9 ' ) i 0 . 88 (3H, d, J=7.41Hz, H-9) i 1.09-1 . 33 (3H, overlapping 
multiplet, H-7 ' ,8') i 1 . 92 (lH, multiplet, H-7 ' ) i 2.22 (2H, dd, 
J=2.22, 10.44Hz, H-2 ' ); 2.91 (lH, dq, J=11.91, 7.39Hz, H-8); 
3.34 (lH, d, J=11.90Hz, H-7) i 3.84 (3H, s, OCH 3) i 5.59 (lH, s, 
H-5 ' ) i 5.68 (2H, dd, J=0.42, 9.29Hz, 02CH2-3 ' ,4 ' ) i 5.90 (2H, 
dd, J=1.46, 4.30Hz, 02CH2-3,4) i 6.17 (2H, dd, J=1.655Hz, 
H-2,6). 13C NMR: 014.17 (C-9) i 14.71 (C-9 ' ) i 18.65 (C-8 ' ) i 
37.16 (C-7 ' )i 44.16 (C-8)i 46.5 (C-2 ' )i 56.31 (C-7)i 56.58 
( OCH 3 - 5) i 6 0 . 42 ( C - 1 ' ) i 91. 32 ( C - 3 ' ) i 98. 62 ( C - 5 ' ) i 101. 2 9 
(02 CH 2- 3 ,4)i 101.47 (02CH2-3',4')i 104.79 (C-6)i 110.92 (C-2)i 
129.99 (C-1) i 134.29 (C-4) i 142.60 (C-5) i 148.32 (C-3) i 177.42 
(C-4 ' )i 200 . 41 (C-6'). 
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3.3.1.1d. Acid-catalyzed hydrolysis of 68 with pTSOH 
A solution of ocobullenone (200mg, S.39x10- 4 mol) in dry 
benzene (10ml) was added into a three-necked round-bottommed 
flask (100ml) containing ethylene glycol (lml, 0.179 mol) in 
dry benzene (SOml). After a Dean-Stark water take-off was in 
place, a catalytic amount of para-toluene sulphonic acid 
monohydrate (p-TSOH) was added and the mixture refluxed for 
14h. The benzene was evaporated and the products dissolved in 
chloroform (SOml). The organic layer was washed with potassium 
bicarbonate (2N, 30m1X3) then with water. The chloroform 
extract was dried over anhydrous magnesium sulphate. The 
products were chromatographed on silica gel column using 
petroleum ether (40-60 0 C)-ethyl acetate (7:S) as eluent to give 






Mp 254-255°C. 1H NMR: 80.63 (3H, d, J=6.50Hz, H-9') i 0.70 (3H, 
d, J=7.69Hz, H-9) i 1.63 (2H, overlapping s, OH-3' ,8') i 1.79 
(lH, dd, J=4.40, 13.36Hz, H-7'a) i 2.05 (lH, d, J=10.53Hz, 
H-2 ' a) i 2.44 (lH, d, J=10.53Hz, H-2'b) i 2.48 (lH, dd, 9.87, 
13 . 35Hz, H-7'b) i 2.70 (lH, dq, 7.71, 11.81Hz, H-8) i 3.45 (lH, 
d, J=11.81Hz, H-7) i 3.85 (3H, s, OCH 3) i 4.54 (lH, s, OH-4') i 
4.79 (lH, ddq, J=4.40, 6.51, 8.89Hz, H-8') i 5.96 (2H, dd, 
13 ' J=1.42Hz, H-2,6). C NMR: 813.04 (C-9) i 20.57 (C-9 ) i 36.57 
(C - 7 ' ) i 44. 83 (C - 8) i 51. 35 (C - 2 ' ) i 56. 83 (C -7, OCH 3) i 58. 41 
(C-1 ' )i 83.59 (C-8')i 84.79 (C-3')i 96.49 (C-5 ' )i 101.47 
(02CH2) i 200.60 (C-6'). Peaks due to C-4' and carbons on the 
benzene ring (both doublets and quaternary carbons) were not 





7 7' 2 ' 
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Mp 199-200 o C. [ex] D23 cm- 1 -263° (CHC1 3 i cO.314). IH NMR: 
80.71 (3H, d, 7.79Hz, H-9) i 1 . 29 (3H, d, J=6.21Hz, H-9') i 1.89 
(lH, dd, J=10.62, 12.91Hz, H-7'a) i 2.01 (lH, d, J=10.55Hz, 
H-2 ' a) i 2.22 (lH, dd, J=5.69, 12.83Hz, H-7'b) i 2.43 (lH, d, 
J=10.53Hz, H-2 ' b) i 2.71 (lH, dq, J=7.73, 11.74Hz, H-8) i 3.53 
(lH, d, J=11.72, H-7) i 3.80 (lH, overlapping m, H-8 ' ) i 3.87 
(3H, s, OCH 3 )i 4.54 (lH, s, OH-3')i 5.57 (lH, s, H-5')i 5.98 
(2H, s, 02CH2) i 6.44 (2H, s, H-2, 6). 13C NMR: 813.02 (C-9) i 
20.68 (C-9 ' )i 39.83 (C-2')i 45.27 (C-8)i 50.51 (C-7 ' )i 55.31 
(C - 7) i 56 . 50 (OCH 3) i 59. 1 7 (C -1 ' ) i 83. 49 (C - 8 ' ) i 84 . 27 (C - 3 ' ) i 
95.87 (C-5 ' )i 101.48 (02CH2)i 131.44 (C-1)i 134.67 (C-4)i 
143 . 06 (C-5) i 148.65 (C - 3) i 187.69 (C-6 ' ) i 200.53 (C-4'). 
Peaks due to C-2 and C-6 were not observed on the 13C spectrum 
(Appendix 72c) . 
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3.3.1.1e. Acid-catalyzed hydrolysis of 68 with mild HCl 
Ocobullenone (68) (llSmg, 3.10xl0- 4 mol) was weighed into a 
three-necked flask (100ml) and methanol (20ml) was added. 
Dilute HCl (l.Sml, 0.2M) was added and the mixture refluxed. A 
further portion of HCl (lml, 2M) was added and the reaction 
allowed to continue for 30h. The reaction mixture was 
evaporated to near-dryness and water (20ml) added. The mixture 
was extracted with chloroform (30mlx3) and the combined 
chloroform washings dried over MgS0 4 . The reaction products 
were chromatographed on a column using petroleum ether-ethyl 
acetate (7:10) as eluent to yield a colourless oil (36mg) (73). 
9 ' 
73 
IH NMR: BO.73 (lH, d, J;7.S8Hz, H-9); 2.10 (3H, overlapping m, 
H-2 ' , H-7'a); 2.56 (2H, m, H-7'b); 2.74 (lH, dq, J;7.SS, 
11. 70Hz, H-8); 3.47 (lH, d, J;11.90Hz, H-7); 3.84 (6H, 
overlapping s, OCH 3-3', OCH 3-S); 5.12 (2H, m, H-9'); 5.48 (lH, 
s, H-S'); 5.73-5.83 (lH, m, H-8'); 5.91 (2H, dd, J;1.49, 
4.31Hz, 02CH2); 6.15 (2H, dd, J;1.S6, H-2,6). 13C NMR: B12.79 
(C-9); 37.07 (C-7'); 47.88 (C-8); 49.11 (C-2'); 53.96 (C-7); 
56.53 (OCH 3-3'); 56.61 (OCH 3-5); 61.04 (C-l'); 81.76 (C-3'); 
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101.08 (C-S')i 101.29 (02CH2)i 104.37 (C-6)i 111.08 (C-2)i 
118.42 (C-9')i 130.44 (C-1)i 134.47 (C-4,8')i 142.62 (C-S)i 
148.41 (C-3)i 179.60 (C-4')i 200.74 (C-6'). 
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3.3.1.2. Bullatone (74) 
The residue from the ethyl acetate extract of the bark of 
Ocotea bullata (12.5g) was fractionated by cc using chloroform 
and final purifications by gradient elution with petroleum 












High Res.-MS: Found 388.1865; C22H2S06 requires 388.1886. 
Mp=1050C. [a] D22 + 175° (CH 2C1 2; cO.08). EI-MS m/z (rel. 
int.): 388 [M] + (8), 209 (35), 208 (42), 193 (16), 182 (18), 
181 (100), 148 (19), 139 (48), 137 (20), 79 (17), 77 (20), 69 
(33), 55 (46), 53 (20). IH NMR: 60.99 (3H, d, J=6.72Hz, H-9); 
1.79 (lH, dd, J=12.67Hz, H-2'b); 2.09 (lH, ddq, J=2.44, 6.78, 
12.59Hz, H-8); 2.25 (lH, dd, J=12.58, 12.66Hz, H-7b); 2.27 (lH, 
overlapping m, H-7 ' b); 2.40 (lH, m, H-1'); 2.56 (lH, dd, 
J=5.19, 12.97Hz, H-2'a); 2.69 (lH, m, H-7'a); 2.87 (lH, dd, 
J=2.44, 12.67Hz, H-7a); 3.80 (3H, s, OCH 3 -4); 3.82 (6H, 
overlapping s, OCH 3 -3,5); 5 . 07 (2H, m, H-9 ' ); 5.53 (lH, s, 
H-5'); 5.60 (2H, dd, very small coupling, 02CH2); 5.70 (lH, m, 
H-8'); 6.27 (2H, s, H-2,6). 13C NMR: 613.34 (C-9); 35.69 
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(C-2')i 36.29 (C-7')i 38.84 (C-7)i 41.18 (C-8)i 42.44 (C-l ' )i 
56 . 23 (OCH 3 - 3 , 5) i 60. 82 (OCH 3 - 4) i 85. 44 (C - 3 ' ) i 99. 85 (C - 5 ' ) i 
9 9 . 9 5 ( 0 2 CH 2) i 10 6 . 15 ( C - 2 , 6) i 11 7 . 66 ( C - 9 ' ) i 13 5 . 18 ( C - 1) i 
136.81 (C-4) i 152.23 (C-3,5) i 175 . 76 (C-4 ' ) i 198.77 (C-6'). 
3.3.2. Cryptocarya woodii 
The fresh bark of Cryptocarya woodii was collected in the 
Karkloof nature reserve, Natal, South Africa in July 1992. The 
dried bark (3.7Kg) was extracted as in 3.2 .. 
3.3.2.1. Goniothalamin (45) 
The crude benzene extract of Cryptocarya woodii was 
fractionated by cc using petroleum ether (40-60 0 C)-ethyl 
acetate (7:2) as eluent. The fractions containing 
goniothalamin were further fractionated on a column and then on 
a chromatotron plate (4mm) with the same solvent system to 






Mp 79-81 0 C (lit. 81-82 0 C). [0] D23 + 169° (CHC1 3 i cO.053) (lit. 
+ 178.5°). lH NMR: 82.52 (2H, ffi, H-5) i 5.09 (lH, ffi, H-6) i 6.08 
(lH, ddd, J=1.93, 3.67, 9 . 82Hz, H-3) i 6.26 (lH, dd, J=6.32, 
IS.95Hz, H-l')i 6.72 (lH, dd, J=1.26, 15.95Hz, H-2')i 6.91 (lH, 
ddd, 3.57, 4.16, 9.88Hz, H-4)i 7.33 (5H, ffi, H-4',5',6',7',8'). 
13C NMR: 829.83 (C-5) i 76.44 (C-6) i 121.54 (C-3) i 125.60 
(C-l ' )i 126.67 (C-4',8')i 128.33 (C-6')i 128.67 (C-5',7')i 
133.05 (C-2')i 135.70 (C-3')i 144.78 (C-4)i 163.92 (C-2). 
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3.3.2.1.1. Epoxidation of 45 
Goniothalamin (45) (200mg, 9.988x10- 4 mol) dissolved in 
dichloromethane (20ml) was added into a stirred solution of 
mCPBA (516mg, 2.99x10- 3 mol) in dichloromethane (30ml) over a 
period of 30min. The reaction mixture was refluxed with 
stirring in a water bath (40-60 0 C) overnight, then washed with 
a solution of 10% sodium bicarbonate (30mlx3), water and dried 
over anhydrous magnesium sulphate. After the solvent was 
removed, the products were fractionated on a column using 
petroleum ether (40-60 0 C)-dichloromethane-acetone-ethyl acetate 
(10:2:1:1) as eluent to afford two crystalline products; 
isogoniothalamin oxide 79 (66mg) and goniothalamin oxide 80 
(llmg) . 
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3.3.2.1.1a. Isogoniothalamin oxide (79) 
4 
79 
Mp 114-117 0 C (lit. 111-114 0 C) 83. [0]0 23 -110.1° (CHC1 3 ; cO.53) 
(lit. -106.0°) 83. IRumaxcm-l (KBr): 1710, 137S, 12'30, 1060, 
1015, 800. EI-MS m/z (rel. int.): 216 [M] + (10), 147 (lS), 131 
(22), 128 (20), 110 (3S), 105 (20), 97 (23), 91 (40), 90 (30), 
82 (91) I 68 (100), 66 (37). IH NMR: 02.S7 (2H, m, H-S); 3.24 
(lH, dd, J=2.04, 3.87Hz, H-1'); 4.06 (lH, d, J=2.04Hz, H-2'); 
4.46 (lH, dd, J=4.00, 5.S9, 9.81Hz, H-6); 6.09 (lH, m, H-3); 
6.93 (lH, m, H-4); 7.30 (SH, overlapping m, H-4',5',6',7',8'). 
13C NMR: 026.16 (C-5); 55.02 (C-1'); 62.10 (C-2'); 7S.33 (C-6); 
121.39 (C-3); 12S.70 (C-4',8'); 128.60 (C-S',7'); 13S.90 
(C-3'); 144.24 (C-4); 162.95 (C-2). Carbon due to C-6 was not 
observed in the 13C spectrum (See Appendix 79c) . 
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Mp 89-91 0 C (lit. 90-94 0 C) 83. [0]0 23 + 104.3° (CHC1 3 ; cO . 045) 
(lit. + 100.7°) 83. EI-MS m/z (rel. int.): 216 [M] + (2), 105 
(19), 97 (28), 91 (66), 90 (41), 89 (46), 82 (100), 81 (30), 69 
(29), 68 (47), 66 (40), 65 (26), 63 (23), 51 (22), 41 (32), 39 
(49). IRvmaxcm-l (KBr): 1715, 1370, 1236, 1026, 800. IH NMR: 
82.30 (2H, m, H-5); 3.26 (lH, dd, J=2.00, 5.12Hz, H-1'); 3.88 
(lH, d, J=2.01Hz, H-2'); 4.46 (lH, ddd, J=5.12, 6.48, 10.25Hz, 
H-6); 6.02 (lH, ddd, J=1.63, 1.99, 9.66Hz, H-3); 6.91 (lH, ddd, 
J=3.45, 8.53, 9.79Hz, H-4); 7.30 (5H, overlapping m, 
H-4' ,5' ,6' ,7' ,8'). 13C NMR: 825.61 (C-5); 56.86 (C-1'); 61.44 
(C-2 ' ); 76.87 (C-6); 121.20 (C-3); 125.68 (C-4',8 ' )*; 128.54 
(C-6'); 128.60 (C-5',7 ' )*. (* = Interchangeable carbons) . 
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3.3.2.2. Cryptocaryolide B (88) 
Fractions (from the benzene extract of C. woodii) containing 
cryptocaryolide B were chromatographed using petroleum ether 
(30-60 0 )-ethyl acetate (9:3), then repeatedly chromatographed 
with petroleum ether (30-60 0 )-ethyl acetate-chloroform 
(9:6:1.5). Chromatography on the chromatotron, using the same 
solvent system, yielded a pure sample of 88 (101mg), a yellow 
oil. 
0-VV19 







High Res.-MS: Found 370.1570; C1sH260S requires 370.3960. 
[a] D 25 +43.8° (CHC1 3 ; cO.63). CI-MS (CH 4 ) m/z (rel. int.): 412 
[M+C 3H7 ] + (0.4), 399 [M+C 2Hs ] + (5), 371 [M+H] + (4), 339 (2), 
313 (3), 312 (12), 311 (100), 251 (6), 219 (1), 191 (10), 173 
(1). IRvmaxcm-1 (Neat): 2950, 1730, 1435, 1370, 1245, 1040, 
960, 820. 1H NMR: 01.23 (3H, d, J=6.24Hz, H-19); 1.77, 2.15 
(2H, overlapping m, H-16); 1.87-2.25 (4H, overlapping m, 
H-8,12); 2.05 (9H, overlapping d, H-20,21,22); 2.40 (2H, m, 
H-4); 4.49 (lH, m, H-5); 4.83-5.13 (3H, overlapping m, H-9, 13, 
17); 6.01 (lH, ddd, J=1.16, 2.49, 9.76Hz, H-2); 6.89 (lH, ddd, 
J=2.80, 5.72, 9.78Hz, H-3). 13C NMR: 019.95 (C-19); 21.13 
(C-20)*; 21.16 (C-21)*; 21.30 (C-22)*; 29.13 (C-4); 38.96 
100 
(C-8)X; 38.96 (C-12)X; 40.16 (C-16)X; 67.63 (C-9)0; 67.77 
(C-13) 0; 68.14 (C-17) 0; 74.89 (C-5); 121.24 (C-2); 144.93 
(C-3); 163.78 (C-1); 170.42 (C-7)+; 170.52 (C-11)+; 170.58 
(C-15)+. *, x, 0, + = Exchangeable carbons. 
3.3.3. Cryptocarya latifolia 
The bark of the natural specimen of Cryptocarya latifolia was 
collected from Qudeni Forest, Natal, South Africa in March 
1993. The dried bark (2.0Kg) was extracted as described in 
3.2 .. 
3.3.3.1. Cryptocaryolide B (88) and A (87) 
The benzene extract (19.2g) was chromatographed on a column 
using petroleum ether (30-60 0 C)-ethyl acetate (9:3) as eluent. 
Fractions containing 87 and 88 were chromatographed on a column 
with petroleum ether-ethyl acetate-chloroform (9:6:1.5) as 
eluent. Fractions containing predominantly cryptocaryolide B 
(88) were further fractionated on a chromatotron (4mm plate) 
using the same solvent system as above to yield a pure sample 
of 88 (2.16g) a colourless to light yellow oil. 
Fractions containing mainly cryptocaryolide A (87) were 
fractionated on a column using petroleum ether-ethyl 
acetate-chloroform (P.E.-E.A.-CHC1 3 ) (9:6:2) as eluent. 
Cryptocaryolide A (87) was further purified by fractionating on 
a chromatotron plate (4mm) using the same solvent system as 
above to yield a pure sample of 87 (270mg), a light yellow oil. 
3.3.3.1a. Cryptocaryolide B (88) 
See 3.3.2.2. for data. 
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High Res.-MS: Found 284.1250; C14H2006 requires 284.1260. 
[0] 0 22 +55.8° (CHC1 3 ; c1.06). CI-MS (CH 4 ) m/z (reI. int.): 325 
(3), 314 (1), 313 (6), 285 [M+1] + (15), 265 (0.4), 253 (4), 243 
(1), 226 (16), 225 (100), 207 (0.5), 193 (4), 183 (2), 182 
(0.5), 166 (3), 165 (23), 147 (3), 121 (5). 1Rvmax cm- 1 
(Neat): 2950, 1733, 1435, 1375, 1245, 1040, 960, 820. 1H NMR: 
81.26 (3H, d, J=6.29Hz, H-15); 1.80, 2.06 (2H, m, H-12); 1.96, 
2.19 (2H, m, H-8); 2.06 (6H, overlapping d, J=6.96Hz, H-16, 
17); 2.42 (2H, m, H-4); 4.52 (lH, ddq, J=4.48, 6.48, 12.00Hz, 
H-5); 4.98 (lH, m, H-9); 5.13 (lH, m, H-13); 6.00 (lH, ddd, 
J=0.96, 2.44, 9.76Hz, H-2); 6.91 (lH, ddd, J=2.27, 5.80, 
9.67Hz, H-3). 13C NMR: 819.97 (C-15); 21.01 (C-17)*; 21.14 
(C-16) *; 29.03 (C-4); 38.94 (C-8); 40.12 (C-12); 67.62 
(C-9,13); 74.82 (C-5); 121.00 (C-2); 144.99 (C-3); 163.69 
(C-1); 170.31 (C-7) +; 170.44 (C-11) +. *, + =Interchangeable 
carbons. 
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3.3.3.2. Foliolide B (91) 
Fractions containing foliolide B (91) were repeatedly 
chromatographed on a column then on a chromatotron plate (4mm) 




19 0yYCH 9 3 






High Res.-Ms: Found 328.3078; C16H2407 requires 328.3590. 
[a] D23 -145° (CHC13i cO.27). IRvmax cm - 1 (Neat): 2945, 1740, 
1430, 1240, 1045, 965, 820. CI-MS (CH 4) m/z (reI. int.): 369 
[M+C2HS]+ (0.7),329 [M+H]+ (0.2),328 [M]+ (0.04),297 (2), 
269 (100), 237 (4), 209 (12), 181 (0.7), 169 (2). 1H NMR: 
81.23 (3H, d, J=6.30Hz, H-18); 1.50-2.25 (8H, overlapping m, 
H-6, la, 14, 17); 2.03 (6H, overlapping d, J=1.88Hz, H-19, 20); 
2 . 81 (2H, m, H - 2); 3. 87 (lH, m, H - 9); 4. 33 (lH, m, H - 3); 4. 88 
( 1H , m, H -15); 4. 96 ( 1H , m, H - 5); 5. 09 ( 1H, m, H -13). 1 3 C NMR: 
820.03 (C-18); 21.23 (C-19) *; 21.34 (C-20) *; 29.50 (C-17); 
36.11 (C-2); 36.87 (C-14); 39.71 (C-6); 39.87 (C-10); 63.11 
(C-9); 67.89 (C-5); 68.35 (C-13); 72.85 (C-15); 169.68 (C-1); 
170.49 (C-7,11). * = Exchangeable carbons. 
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3.3.3.3. Cryptofolione (81) 
Fractions containing 81 were repeatedly chromatographed on a 
column then on a chromatotron plate (2mm) using 
E.A.-CH2C12-P.E.-MeOH (5:2:7:1) as eluent. A pure yellow oil 






High Res.-Ms: Found 314.1503; C19H2204 requires 314.1518. 
[ex] D2 3 +270 (CHC1 3 . cO.52). IRvmaxcm-1 (Neat): 3440, 2942, , 
170 0, 13 85, 125 0, 1055, 975, 825 , 755, 700. 1 H NMR: 81. 78 ( 2 H , 
fi, H-5 ' ); 2.38 (2H, m, H-3 ' ); 2.41 (2H, m, H-5); 3.46 (2H, 
overlapping m, OH-4' ,6'); 4.05 (lH, m, H-4'); 4.63 (lH, m, 
H-6'); 4.88 (lH, m, H-6); 5.63 (lH, dd, J=6.33, 15.66Hz, H-1'); 
5.82 (lH, m, H-2'); 6.00 (lH, overlapping m, H-3); 6.23 (lH, 
dd, J=5 . 81, 15.99Hz, H-7'); 6.61 (lH, dd, J=1.01, 16.00Hz, 
H-8'); 6.83 (lH, overlapping m, H-4); 7.23 (5H, overlapping m, 
H-10', 11 ' ,12' ,13' ,14'). 13C NMR: 829.63 (C-5); 40.35 (C-3'); 
42.29 (C-5'); 68.04 (C-4 ' ); 70.05 (C-6 ' ); 77.96 (C-6); 121.29 
(C-3); 126.43 (C-10',14'); 127.56 (C-12 ' ); 128.55 (C-11',13 ' ); 
129.61 (C-8 ' ); 129.70 (C-1 ' ); 131.33 (C-2'); 131.93 (C-7'); 
136.65 (C-9 ' ); 145.10 (C-4); 164.27 (C-2). 
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3.3.3.3.1. Reactions on Cryptofolione (81) 
3.3.3.3.1a. Acetonide derivative of Cryptofolione 
A catalytic amount of pTSOH (22mg) was added to a solution of 
cryptofolione (81) (1.597g, 5.08x10- 1 mol) in dimethyl 
formamide (5ml) and 2,2-dimethoxypropane (20ml). The reaction 
mixture was refluxed for 14h. Sodium bicarbonate (0.5%, 150ml) 
was added and the mixture extracted with chloroform (3x100ml). 
The combined chloroform extracts were dried over anhydrous 
MgS0 4 and chromatographed on a column using 
E.A.-CHC1 3-P.E.-MeOH (5 : 2:20:1) as eluent. The acetonide 
derivative 82 (481mg) was obtained as a yellow oil. 
16 ' 17 ' 






[ex] D23 +79 0 (CH 2C1 2; c1.36). IRymaxcm-1 (Neat): 2940, 1705, 
1380, 1255, lOSS, 970, 825, 750. 1H NMR: 01.40 (6H, 
overlapping s, H-16' ,17 ' ); 1.76 (2H, m, H-5'); 2.30 (4H, 
overlapping m, H-5, 3'); 3.92 (lH, m, H-4 ' ); 4.48 (lH, m, 
H-6 ' ); 5.62 (lH, m, H-1 ' ); 5.80 (lH, m, H-2 ' ); 6.01 (lH, ddd, 
J=1 . 83, 3 . 67, 9.82Hz, H-3); 6.20 (lH, dd, J=6.22, 16.01Hz, 
H-7 ' ); 6.54 (lH, dd, J=0.77, 15.99Hz, H-8'); 6.77 (lH, ddd, 
J=4.22, 8.45, 9.89Hz, H-4); 7.28 (5H, overlapping m, H-10', 
11 ' ,12',13 ' ,14') . 13C NMR: 024.59 (C-17')*; 25.59 (C-16 ' )*; 
29.60 (C-5); 37.31 (C-5'); 38.44 (C-3'); 65.73 (C-4 ' ); 67.51 
105 
(C-6')i 77.79 (C-6)i 100.26 (C-1S')i 121.14 (C-3)i 126.40 
(C-10', 14')i 127.58 (C-12')i 128.51 (C-11', 13')i 129.46 
(C-1')i 129.87 (C-7')i 130.04 (C-8')i 130.40 (C-2')i 136.46 
(C-9') i 145.08 (C-4) i 163.81 (C-2). * =Exchangeable carbons. 
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3.3.3.3.1b. Oxidation of Cryptofolione 
81 (l.076g, 3.42x10- 1) in anhydrous CH 2Cl 2 (10ml) was added to 
the orange suspension of pyridinium chlorochromate (2.21g, 
1.026x10 - 4 ") in anhydrous CH 2Cl 2 (25ml) which as a result 
changed to a brown-black colour. The reaction mixture was 
refluxed for 3h under nitrogen. After cooling, dry diethyl 
ether (50ml) was added. The brown-black suspension was 
decanted leaving a black gum, which was washed with diethyl 
ether, at the bottom of the flask. The combined organic 
solvents were filter, concentrated and chromatographed on a 
column using E.A.-CHCI 3-P.E.-MeOH (4:2:7:1) to give 




5 ' 3 ' 1 ' 
83 
High Rea.-Ms: Found 312.1360; C19H2004 requires 312.1361. 
[oJ D23 +101 0 (CH2CI2; c.0.86). DIP CI-MS (CH 4) m/z (reI. 
int.): 353 (1), 341 (1), 314 (6), 313 [M+HJ + (31), 295 (17), 
277 (3), 209 (3), 207 (3), 195 (4), 187 (4), 175 (17), 167 
(35), 149 (39), 147 (100), 131 (53), 107 (15). IH NMR: 02.31 
(2H, m, H-3'); 2.45 (2H, m, H-5); 2.61 (2H, m, H-5 ' ); 3.55 (lH, 
broad s, OH-4 ' ); 4 . 32 (lH, broad m, H-4 ' ); 4.91 (lH, m, H-6); 
5 . 71 ( 1H, m, H -1 ' ); 5. 91 (lH, m, H - 2 ' ); 6. 03 (lH, m, H - 3); 6. 74 
(lH, d, J=16.20Hz, H-S ' ) i 6.90 (lH, m, H-4); 7.49 (5H, 
overlapping m, H-10 ' , 11 ' , 12 ' , 13 ' , 14'); 7.52 (lH, d, 
J=16 . 16Hz, H-7 ' ). 13CNMR: 029.62 (C-5)i 39.29 (C-3')i 46.19 
01 ' .: 
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. ) i 77 . 95 (C-6)i 121.32 (C-3)i 126.12 (C-7')i 
; 128.97 (C-11',13')i 129.80 (C-1 ' )i 130.80 
':: - 2 ' )i 134.06 (C-9')i 143.71 (C-8')i 145.02 
.: ; 200.46 (C-6'). 
~· ation of Cryptofolione 
-=-1 (200mg, 6.369x10- 4 mol) in pyridine (5ml) 
-=~ydride (5ml). The mixture was refluxed for 
-~ added and the mixture extracted with CH 2 Cl 2 
_ ~nic layer was then extracted with HCI (0.5N, 
=~ned organic solvent was dried over anhydrous 
~ was chromatographed on a column using 
_ : 2:10) to give a hygroscopic yellow 
--==:J d 85 (107mg). 
~ o 0 ~ o 0 
o 
5 ' 3 ' l ' 
85 
. 3 +53 0 (CHCI 3 i cO.053). CI-MS (CH 4 ) m/z 
6 ), 398 (31), 397 (100), 396 (21), 395 
=- (9), 223 (4), 207 (7). 1H NMR: 81. 93 (2H, m, 
- ~, H-15 ' )i 2.06 (3H, s, H-17')i 2.28 (4H, 
~= ' , 5) i 4.89 (lH, m, H-6) i 5.05 (lH, m, H-4') i 
. ; 5.60-5.86 (2H, overlapping m, H-1', 2 ' ) i 
-=rlapping m, H-3, 7 ' ) i 6.62 (lH, dd, J=0.55, 
108 
lS.99Hz, H-8 ' ) i 6 . 87 (lH, ddd, J=4.21, 8 . 42, 9.89Hz, H-4); 7.32 
(SH, overlapping m, H- 10 ' ,11 ' ,12 ' ,13 ' ,14'). 13C NMR: 821.06 
(C-1S ' )*i 21.17 (C-17 ' )*; 29.S7 (C-S); 37.SS (C-3 ' ); 38.44 
(C-S ' ); 68.66 (C-4 ' ); 70.68 (C-6'); 77.63 (C-6)i 121.49 (C-3)i 
126 . S7 (C-10 ' , 14 ' ); 126.90 (C-7 ' )i 128.08 (C-12 ' )i 128.S7 
(C-11 ' , 13'); 129.28 (C - 2 ' ); 130.43 (C-1 ' )i 132.76 (C-8 ' )i 
13S . 98 (C-9 ' ); 144.70 (C-4); 163.89 (C-2); 170.19 (C-16')+i 
170 . 47 (18 ' ) +. *, + = Exchangeable carbons. 
3.3.3.3.4. Foliolide A (90) 
The chloroform extract (S . 2S0g) of Cryptocarya latifolia was 
fractionated on a column with E.A.-CH 2C1 2-P.E.-MeOH (S:2:7:1). 
Fractions containing foliolide A (90) were subsequently 
chromatographed with E.A.-CH2C12-P.E.-MeOH (9:2:4:1), (8:2 : 3:1) 
then (7:2:4 : 1) on a column and finally with (9:2:2:1) on a 




[a] D24 -128° (CHC1 3 ; cO . 04). 1Rvmax cm - 1 (Nujol): 2940. 1733, 
143S, 1045. 960. CI-MS (CH 4) m/z (reI. int.): 24S [M+H]+ (53), 
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191 (17), 183 (25), 165 (22), 157 (37), 155 (18), 141 (100), 
139 (39). IH NMR: 81.18 (3H, d, J=6.16Hz, H-13) i 1.52 (2H, fi, 
H-6) i 1.59, 1.73 and 2.08 (2H, fi, H-10) i 1.59 (2H, fi, H-8) i 
2.01 (2H, fi, H-12) i 2.86 (2H, fi, H-2), 3.67-4.11 (5H, 
overlapping fi, H-5, 7, 9, OH-7, OH-9) i 4.41 (lH, fi, H-3) i 4.89 
(lH, fi, H-11). 13C NMR: 823.64 (CH 3 ) i 29.40 (C-13) i 36.35 
(C-2), 37.07 (C-10) i 42.91 (C-8) i 44.89 (C-6) i 65.94 (C-3) i 
66.41 (C-7)*i 68.13 (C-5)i 71.91 (C-9)*i 72.62 (C-11)i 169.56 
(C-1). * = Interchangeable carbons. 
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3.4. Cryptocarya myrtifolia 
The benzene extract (42.2g) of Cryptocarya myrtifolia was 
fractionated on a column using P.E.-E.A.-CHCI 3 (3:3:1) as 
eluent. Fractions containing cryptofolione (81) were 
concentrated and chromatographed as in 3.3.3.3. to yield 81 
(3.516g) . 
3.4.1. Myrtifolione (86) 
The chloroform extract of C. myrtifolia (8.78g) was 
fractionated on a column with CH 2 CI 2 -MeOH (15:2) as eluent. 
Fractions containing myrtifolione (86) were further and 
repeatedly chromatographed on a chroma tot ron using 
Hexane-E.A.-CH 2 CI 2 -MeOH (7:3:3:1) as eluent. A white, 




Mp 103-105 0C (Highly hygroscopic compound). [cd 0 23 +690 
(CHCI 3 i cO.050). DIP CI-MS m/z (reI. int.): 371 (2), 343 (15), 
331 [M-HJ + (2), 315 (62), 213 (16), 211 (31), 193 (28), 185 
(lCO), 167 (68), 155 (51), 141 (71), 131 (94), 117(46). IH 
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NMR: 81. 88 (2H, ffi, H-3 ' ) i 1. 98 (2H, ffi, H-5') i 2.07 (2H, ffi, 
H-1 ' )i 2 . 02 (2H, ffi, H-5)i 4 . 50 (lH, ffi, H-2 ' )i 4.76-4.92 (2H, 
overlapping ffi, H-4 ' , 6) i 5.04 (lH, ffi, H- 6 ' ) i 5.62-5.90 (3H, 
broad ffi , OH-2' ,4 ' ,6') i 5.94 (lH, ddd, J=1.10, 2.67, 9.83Hz, 
H-3)i 6.59 (lH, ffi, H-4)i 6.65 (lH, dd, J=5.40, 15.93Hz, H-8 ' )i 
6.89 (lH, dd, J=1.10, 16.02Hz , H-7 ' ) i 7 . 19-7.38 (5H, 
overlapping ffi, H-10 ' , 11 ' ,1 2',13', 14 ' ). 13C NMR: 829.83 
(C-5)i 44.19 (C-5 ' )i 46.83 (C-1') i 46.91 (C-3 ' )i 65.19 (C-2')i 
65.90 (C-4 ' )i 69.90 (C-6')i 76.86 (C-6)i 121.78 (C-3)i 127.26 
(C-10 ' , 14 ' )i 128.02 (C-12 ' )i 128.98 (C-7')i 129.48 (C-11', 
13 ' )i 136.31 (C-8 ' )i 138.17 (C-9 ' ) i 146 . 46 (C-4)i 164.98 (C-2). 
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5. APPENDIX 
A collection of all the NMR spectra, in numerical order of the 
compounds as they are numbered in the Introduction and 
Discussion. Spectra were recorded at 200MHz (lH NMR) and 50MHz 
(13C NMR) unless labelled otherwise. 
a = IH NMR 
b = expanded IH NMR 
c 1 'C NMR 
d = IH-IH COSY 
e = IH_IH DELAYED OR RELAYED COSY 
f IH_13C HETCOR 
g = IH_13C DELAYED HETCOR 
s NMR solvent 
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